Office of Research and Graduate Studies Stafffile.cop.ufl.edu/millard/annual_reports/AR1112.pdf ·...
Transcript of Office of Research and Graduate Studies Stafffile.cop.ufl.edu/millard/annual_reports/AR1112.pdf ·...
ii
Office of Research and Graduate Studies Staff
William J. Millard, Ph.D.
Executive Associate Dean
Professor, Department of Pharmacodynamics
Gary Hamlin
Sr. Grants Specialist
Deborah Bambarola
Grants Specialist
José Ortiz
Office Assistant
iii
Table of Contents
Section Page
Introduction .............................................................................................................................................................. 1
Graduate Education and Program Activities ........................................................................................................ 2
Graduate Programs in the College ........................................................................................................................ 2
Graduate Studies Committee Activities ................................................................................................................ 3
College of Pharmacy Graduate Student Organization ........................................................................................... 3
Graduate Faculty, Graduate Student, Post-doctoral Fellow, Visiting Scholar
and Exchange Student Demographics .............................................................................................................. 4
PharmD/Ph.D. Students in Graduate Programs in the College of Pharmacy ........................................................ 8
FDA/CDER Students in the Master’s Program ..................................................................................................... 9
Graduate Student Recruitment Activities .............................................................................................................. 9
Exchange Students in the College of Pharmacy .................................................................................................... 9
Graduate Student Graduation Activities ............................................................................................................... 10
Graduate Student Funding and Awards ................................................................................................................. 16
Graduate Minority Activities ................................................................................................................................ 19
Research Activities in the College of Pharmacy .................................................................................................... 20
Grant and Contract Efforts and Funding ............................................................................................................... 20
Clinical Laboratories Income ................................................................................................................................ 25
Licensing and Royalty Income .............................................................................................................................. 25
Graduate Student Research Activities and Awards ............................................................................................... 25
Professional Student Research Activities and Awards .......................................................................................... 26
U.S.-Thai Consortium Activities ............................................................................................................................. 28
History of the U.S.-Thai Consortium. ................................................................................................................... 28
11th
U.S.-Thai Pharmacy Education Consortium Meeting .................................................................................... 28
ORGS Coordinated Events...................................................................................................................................... 30
Post-baccalaureate Reception ............................................................................................................................... 30
Annual Research Showcase and Awards Recognition Day ................................................................................... 30
Other ORGS Activities ............................................................................................................................................ 32
Committee Assignments........................................................................................................................................ 32
Conferences Attended Related to ORGS Activity ................................................................................................ 33
Appendices ................................................................................................................................................................ 34
A= Letter to Graduate Applicants ......................................................................................................................... 35
B= Complete Listing of Extramural Support by Department and Faculty ............................................................ 37
C= 25th
Annual Research Showcase and Awards Recognition Day Booklet ........................................................ 43
1
Introduction
The Office of Research and Graduate Studies (ORGS) was established in the College of Pharmacy (COP) in 1989 as the
major unit within the College responsible for the oversight of all aspects of the graduate programs (M.S. and Ph.D.) as well as
research activities. Within the purview of these two major activities are a number of functions that are coordinated by ORGS
personnel and make up the daily operations of the office.
The structure of the ORGS is outlined in Figure 1. Dr. William J. Millard, Professor in the Department of
Pharmacodynamics, accepted the role as Associate Dean for Research and Graduate Studies on an acting basis in January 1995,
and then on a permanent basis in August 1997. On January 1, 1999, Dr. Millard accepted the permanent position as Executive
Associate Dean for the College of Pharmacy and as part of this position maintains oversight of the ORGS and reports all ORGS
activities directly to the Dean of the College.
Graduate Coordinator, Pharmacodynamics
Joanna Peris, Ph.D.
Graduate Coordinator, Pharmaceutics
Tony Palmieri, R.Ph., Ph.D.
Graduate Coordinator, Medicinal Chemistry
Raymond Bergeron, Ph.D.
Graduate Coordinator, Pharmaceutical
Outcomes and Policy
Almut Winterstein, Ph.D.
Graduate Coordinator, Pharmacotherapy &
Translational Research
Reginald Frye, PharmD, Ph.D.
Executive Associate Dean
William J. Millard, Ph.D.
Sr. Grants Specialist
Gary Hamlin
Dean, College of
Pharmacy
William H. Riffee, R.Ph.,
Ph.D.
Figure 1: Administrative Flow Chart for the ORGS
Director, Forensics Sciences Program
Ian Tebbett, Ph.D.
Grants Specialist
Deborah Bambarola
Office Assistant
Jose Ortiz
The Executive Associate Dean is responsible for monitoring all graduate student applications, quality of graduate students
and the progression of students through the graduate programs in the College. The Executive Associate Dean's role also
includes monitoring of the quality of graduate programs and seeking ways to expand or improve graduate education within the
COP. The Executive Associate Dean also acts as the major liaison between the Graduate School and the Office of Research,
Technology and Graduate Education (ORTGE) at the University of Florida and the COP faculty and graduate students.
Information concerning graduate programs and education within the COP is communicated from the Executive Associate
Dean to faculty or graduate students through the Departmental Chairs and Graduate Coordinators. This year the college had
two changes in graduate coordinators during the academic year. Dr. Taimour Langaee assumed the graduate coordinator role in
Pharmacotherapy & Translational Research in January 2012 owing to Dr. Reginald Frye assuming the Department Chairs
position. In March 2012 owing to the retirement of Dr. Raymond Bergeron, Dr. Hendrik Luesch assumed the graduate
coordinator position in Medicinal Chemistry. The Graduate Studies Committee and COP Graduate Student Organization assist
the Executive Associate Dean in the responsibility of governing graduate education in the COP (see: Graduate Education and
Program Activities, Graduate Studies Committee Activities, College of Pharmacy Graduate Student Organization).
Related to research activities, the Executive Associate Dean has the major responsibility to see that faculty remain active in
their individual research programs and to assist them in the grant or contract submission process. It is the Executive Associate
Dean’s responsibility to ensure that all grants are submitted and logged through UF in the proper manner. This includes making
sure that proper contractual arrangements and documentation are completed and that each contract or grant contain the proper
faculty percent effort and salary offset dollars, as well as correct Facilities & Administrative (F&A) cost and graduate student
support. The Executive Associate Dean also sees that information relevant to research is communicated to the proper faculty or
personnel within the COP.
The Executive Associate Dean is assisted in the ORGS by three staff members; a Sr. Grants Specialist, a Grants Specialist
and an Office Assistant. In January 2011 a Sr. Grants Specialist position was created and filled by Mr. Gary Hamlin. Since
June 2001, the Grants Specialist has been Ms. Deborah Bambarola. In July 2011, Mr. José Ortiz started to assume some of the
responsibilities related to the graduate duties as the Office Assistant. These three positions work together to handle the daily
operations of the ORGS. Some of these duties include the tracking and reporting of graduate information and students, assisting
students with various problems and graduate course registration, submission of needed reports to the COP, University and
outside agencies, the coordination of the various functions of the ORGS, as well as the tracking and filing of new research
grants and the monitoring of post-award activities.
The remainder of this report will deal with COP Graduate Programs, COP Research Activity, U.S.-Thai Consortium
Activities, Coordinated Functions and Other Activities of the ORGS.
2
Graduate Education and Program Activities
Graduate Programs in the College of Pharmacy
The College of Pharmacy offers both residential and online graduate programs. There is only one residential Ph.D.
program administered through the College: Ph.D. in Pharmaceutical Sciences. Under the umbrella of the Ph.D. in
Pharmaceutical Sciences (established in 1932) there are four graduate specialty programs that are recognized in the College of
Pharmacy by the Graduate School. These graduate specialties are: Medicinal Chemistry (recognized in 1978),
Pharmacodynamics (recognized in 1989), Pharmaceutical Outcomes and Policy (recognized in 1996), and Pharmaceutics
(recognized in 1998).
In February, the Department of Pharmacotherapy & Translational Research received approval from the Graduate School
for their stand-alone graduate concentration in “Clinical Pharmaceutical Science”. This new concentration will be effective in
the Fall 2012 Semester. This concentration was initiated in 2004 when faculty within the Department saw that there was a
critical need for clinically-trained professionals to have rigorous research training in order to facilitate and grow translational
research in the Pharmaceutical and Biomedical Sciences. This is a major milestone in our College as now each Department has
their own graduate concentration under the Pharmaceutical Sciences umbrella. Tied to each of the residential Ph.D. programs
in the College is an associated Master of Science (M.S.) in the Pharmacy Program. The M.S. in Pharmacy in the Departments
of Medicinal Chemistry, Pharmaceutics, and Pharmacodynamics requires each student to prepare and defend a thesis as part of
their degree. Pharmaceutical Outcomes and Policy and Pharmacotherapy & Translational Research have the option of a thesis
or non-thesis M.S. degree. In general, residential graduate students are discouraged from entering directly into an M.S. in
Pharmacy; instead, students are strongly encouraged to enter into one of the Ph.D. programs. However, students may opt for
the M.S. degree in their discipline if they find that the Ph.D. degree is not what they desire after entering the program.
The U.S. Food and Drug Administration/Center for Drug Evaluation and Research (FDA/CDER) in collaboration with the
University of Florida, offered a residential educational program aimed at attracting scientists and health professionals to the
FDA/CDER. Due to federal budgetary reductions to the FDA, this program has been temporarily discontinued. This UF/FDA
Graduate Program provided participants with two years of advanced graduate education at the Masters (M.S.) or Doctorate
(Ph.D.) level designed to advance scientific training and analysis involved in the safety and regulatory decisions unique to the
center’s and agency’s mission. This program graduated its second cohort resulting in a total of 15 students who have
successfully completed the program. Graduating students serve an assignment at the FDA/CDER for at least four years after
graduation. One student graduating with a M.S. degree from the second cohort is continuing his Ph.D. studies in the
Department of Pharmaceutical Outcomes and Policy .
The College also offers a number of online programs leading to the M.S. degree. The University of Florida online
Forensic Science Program has grown to become the largest graduate forensic program in the world with almost seven hundred
enrollments each semester from some 40 different countries. Designed to meet the needs of working professionals, the program
consists of four areas of concentration: Forensic Toxicology, Forensic Drug Chemistry, Forensic DNA & Serology and
Forensic Science. Within each concentration the program offers a Master’s Degree or a Certificate. The Toxicology
concentration is provided by the College of Veterinary Medicine while the Drug Chemistry, DNA & Serology, and Forensic
Science concentrations are provided by the College of Pharmacy. The program has received national recognition for excellence
by the American Distance Education Consortium and the U.S. Distance Learning Association.
Sister programs in Pharmaceutical Chemistry and Clinical Toxicology were introduced in 2009 and 2011 respectively. The
Pharmaceutical Chemistry program is primarily designed for those already employed, or seeking employment, in the
pharmaceutical industry, while the Clinical Toxicology program appeals to emergency room and poison control center staff.
In FY 05/06, the Department of Pharmaceutical Outcomes and Policy initiated an online Master's program that provides
the necessary expertise and credentials to understand and apply issues relating to regulatory policies and law, and to serve as an
authoritative source in the workplace on regulatory matters. Because the program is open to students from all academic and
professional backgrounds (PharmD not required), this unique Master's program serves as a career pathway for people both
inside and outside the pharmacy industry to pursue careers with pharmaceutical companies, governmental agencies,
professional associations, managed care and research organizations, benefits management companies, health systems and
industry. The Master of Science in Pharmacy, with concentration in Pharmaceutical Outcomes and Policy, offers several
specialty tracks: Pharmacy Regulation & Policy, Applied Pharmacoeconomics, Clinical Research Regulation in Pharmacy,
Patient Safety & Medication Risk Management, Drug Regulatory Affairs, and Institutional Pharmacy Leadership. Courses for
this 30-credit program are held online in highly-interactive, live, virtual classrooms, and students are required to attend two or
three weekend seminars and to take a final comprehensive exam on campus. Currently, the program has approximately 172
enrolled students and 196 alumni.
The newest online Master’s program in the College is the Master of Science in Pharmacy with concentration in
Medication Therapy Management (MS-MTM). The MS-MTM program is a 33-credit degree program designed for working
pharmacists who wish to continue their career while gaining innovative patient care and business skills needed to become a
leader in the groundbreaking field of medication therapy management. The online program can be completed in as little as five
3
semesters and requires at least one visit to the main campus for a week-long live seminar. The MS-MTM program currently has
59 students enrolled, and the first cohort will graduate in Fall 2012.
Graduate Studies Committee (GSC) Activities
During FY 91/92 all Graduate Studies/Programs were decentralized in the College from the ORGS and into each of the
individual departments. With this decentralization the review or setting of graduate policies and graduate student recruitment
is now in the hands of the individual departments. To assist the ORGS in the management of graduate activities in the College,
the Graduate Studies Committee (GSC) was established.
The primary goal for the GSC is to be a medium through which graduate and research programmatic goals are reviewed on
a continual basis and aligned with the goals of the College and the University (i.e., continuous quality improvement, CQI).
The primary charge of the GSC is to review and make recommendations on graduate programs in the College of Pharmacy.
This would include both new and existing graduate programs. The GSC is involved in considering how the College can
attract/fund more graduate students with an emphasis on bringing in more U.S. students and professional (pharmacy) students.
This committee is also involved in reviewing any future major mandate(s) from the Graduate School that may impact the
functioning of the overall graduate program within the College (i.e., stipends; tuition waivers). The committee continues to
select finalists in the College’s Spring Research Competition and also makes recommendations on how to improve this College
function.
The makeup of the GSC includes a graduate coordinator representative from each of the departments and the
President of the COP Graduate Student Organization. The Executive Associate Dean serves as the non-voting chair, and
the Dean as ex-officio member of the committee. The Office Assistant sits in on all committee meetings as the recording
secretary. Representatives on the Committee were:
Non-voting Chair: Dr. William Millard Office of Research and Graduate Studies
Voting Members: Drs. Raymond Bergeron & Hendrik Luesch Medicinal Chemistry
Dr. Joanna Peris Pharmacodynamics
Dr. Almut Winterstein Pharmaceutical Outcomes and Policy
Dr. Tony Palmieri Pharmaceutics
Drs. Reginald Frye & Taimour Langaee Pharmacotherapy & Translational Research
Dr. Ian Tebbett Forensic Science Program
Mr. Jonathan Schelfhout President of COP Graduate Student Organization
Ex-officio Member: Dr. William Riffee Dean
The GSC met ten times throughout the year. Some of the issues that were deliberated included:
Selection of the FY 12/13 Graduate School Fellowship Awardees
Review of the use of Liberty Award monies for graduate students in each of the departments
Use of State Line OPS monies for graduate student stipends
Establishment of TA assignments for each of the semesters
Continual review of graduate programs in each deparment
Establishment of goals and objectives for each graduate program within the College
Selection of finalists for the 25th
Annual Research Showcase and Awards Recognition Day
College of Pharmacy Graduate Student Organization
The COP Graduate Student Organization (GSO) is an avenue by which graduate students can discuss common issues
related to graduate education and bring their concerns to the attention of the Executive Associate Dean for Research and
Graduate Studies. The COP GSO elects a president on an annual basis. The president of the organization coordinates and runs
the meetings (1-2 per year) and also sits in on the Graduate Studies Committee as a voice for the graduate students. Mr.
Jonathan Schelfhout, from the Department of Pharmaceutical Outcomes and Policy, served as president of the organization.
At the beginning of each Fall semester, the ORGS sponsors a luncheon for COP graduate students to promote a forum for
exchange of information between each other and the ORGS.
4
Graduate Faculty, Graduate Student, Post-doctoral Fellow, Visiting Scholar and Exchange Student
Demographics
The College has 55 graduate faculty members who are closely involved in the training of all graduate students, post-
doctoral fellows and visiting students and scholars. A complete listing of the college graduate faculty, by department, can be
found in Table 1. The COP accepted 12 new students into the various Graduate Programs. A listing of all residential
graduate students according to their department with their date of entrance into the graduate program, degree sought and
mentor is found in Table 2. Ninety-three graduate students were engaged in residential studies leading to either the M.S. or
Ph.D. degree this year. The COP graduated 14 Ph.D. students and 11 M.S. students (see: Graduate Student Graduation
Activities). In addition, 851 graduate students were pursuing a M.S. degree program by online education. Noteworthy, is that
159 (18.7%) of these students graduated this past academic year.
Table 3 outlines the overall demographics of the residential graduate student population within the COP. This year the
number of male students compared to female students was a 41/59 percent male/female ratio. The college has a 39/61 percent
American/Foreign student ratio as well. The percent of U.S. minority students was 9.7% (9 of 93) for FY 11/12. This is an
increase from the previous year of 6.7% (6 of 89). Distribution of graduate students among the departments is illustrated in
Table 4. This year the Department of Pharmaceutical Outcomes and Policy had the highest number of students with 29;
Pharmaceutics had 25; Medicinal Chemistry and Pharmacodynamics both had 14; and Pharmacotherapy & Translational
Research had 11 students pursuing graduate degrees. GPA and graduate program entrance test scores for both the entire
population of the residential graduate students and the entering class of 11/12 are shown in Table 5.
For the sake of completeness, a listing by department of Post-doctoral Fellows and Visiting Scholars in the COP is
illustrated in Table 6 and a listing of Exchange Students is listed in Table 10. Noteworthy is that the COP Ph.D./M.S.
graduate program had 1 student from Pharmaceutical Outcomes and Policy leave the graduate program during FY 11/12.
Table 1: Graduate Faculty
Department/Center Faculty Name
Medicinal Chemistry Raymond Bergeron Hendrik Luesch
Raymond Booth Kenneth Sloan
Oliver Grundmann Ian Tebbett
Margaret James Donna Wielbo
Pharmaceutics/Center for Nicholas Bodor Sven Normann
Drug Discovery & Center Veronika Butterweck Tony Palmieri
for Drug Interaction Hartmut Derendorf Stephan Schmidt
Research and Education Guenther Hochhaus Sihong Song
Cary Mobley
Pharmacodynamics Dorette Ellis Bin Liu
Jason Frazier Michael Meldrum
Carrie Haskell-Luevano William Millard
Michael Katovich Joanna Peris
Eric Krause William Riffee
Maureen Keller-Wood
Pharmaceutical Outcomes and Diane Beck Earlene Lipowski
Policy/Center for Research David Brushwood Folakemi Odedina
in Pharmaceutical Care Joseph Chris Delaney Richard Segal
Abraham Hartzema Thomas Smith
Teresa Kauf Burcin Unel
Carole Kimberlin Almut Winterstein
Pharmacotherapy & Translational Research/ Rhonda Cooper-DeHoff Larry Lopez
Center for Pharmacogenomics Abdolreza Davoodi-Semiromi John Markowitz
Paul Doering Michael McKenzie
Reginald Frye Charles Peloquin
Leslie Hendeles Karen Whalen
Julie Johnson Yan Whisler
Taimour Langaee Haojie Zhu
5
Table 2: Graduate Students in Residential Programs
Department/Center Name Date Expected Degree
Mentor Entered Grad Date Sought
Medicinal Chemistry Ambadapadi, Sriram Aug. 07 May. 13 Ph.D. James
Bousquet, Michelle Aug. 10 Aug. 14 Ph.D. Luesch
Felsing, Daniel * Aug. 11 May. 15 Ph.D. Booth
Jackson, Erin Aug. 10 Aug. 14 Ph.D. James
Kondabolu, Krishnakanth Aug. 08 May. 13 Ph.D. Booth
Merritt, Kristen ** Aug. 02 Aug. 11 Ph.D. James
Metavarayuth, Kamolrat Aug. 10 Aug. 12 M.S. Luesch
Montaser, Rana Aug. 08 Aug. 13 Ph.D. Luesch
Salvador, Lilibeth Aug. 08 Aug. 13 Ph.D. Luesch
Synovec, Jennifer Aug. 09 May. 13 Ph.D. Sloan
Thiele, Nikki * Aug. 11 May. 16 Ph.D. Sloan
Travers, Sean ** Aug. 06 Aug. 11 Ph.D. Booth
Wang, Rui Aug. 07 Dec. 12 Ph.D. Luesch
Zhong, Guo * Aug. 11 May. 16 Ph.D. James
Pharmaceutics Akbar, Mohammad Jan. 10 Dec. 14 Ph.D. Song
Alalaiwe, Ahmed Aug. 10 Aug. 14 Ph.D. Frye
Albassam, Ahmed Aug. 10 Aug. 14 Ph.D. Hochhaus
Barth, Aline Aug. 10 Aug. 14 Ph.D. Derendorf
Bhagwat, Sharvari * Aug. 11 May. 15 Ph.D. Hochhaus
Chen, Guanming * Aug. 11 May. 15 Ph.D. Song
Chen, Mongjen Aug. 09 May. 13 Ph.D. Song
Conrado, Daniela Jan. 09 Dec. 13 Ph.D. Derendorf
Fueth, Matthias ** Aug. 07 Dec. 11 Ph.D. Song
Hassan, Am Mahbub Aug. 05 Dec. 12 Ph.D. Hochhaus
Haug, Karin Jan. 09 Dec. 13 Ph.D. Butterweck
Kandala, Bhargava Aug. 09 May. 13 Ph.D. Hochhaus
Le, Huong ** Aug. 07 May. 12 Ph.D. Song
Li, Li Jan. 09 Dec. 13 Ph.D. Butterweck
Liu, Xuan Aug. 09 May. 13 Ph.D. Butterweck
Naik, Runa ** Aug. 07 Aug. 11 Ph.D. Derendorf
Song, Xuyang June. 09 May. 13 Ph.D. Derendorf
Sun, Wan Aug. 08 May. 13 Ph.D. Derendorf
Sy, Sherwin Aug. 10 Aug. 14 Ph.D. Derendorf
Tatipali, Manasa Jan. 10 May. 14 M.S. Palmieri
Vieira, Manuela ** Aug. 07 Aug. 11 Ph.D. Derendorf
Waters, Chad Jan. 09 May. 13 Ph.D. Palmieri
Weber, Benjamin Jan. 09 Dec. 13 Ph.D. Hochhaus
Zhou, Di Jan. 11 Dec. 15 Ph.D. Hochhaus
Zhuang, Luning * Jan. 11 Dec. 15 Ph.D. Derendorf
Clinical Pharmaceutical Chang, Shin-Wen * Aug. 11 May. 15 Ph.D. Cooper-DeHoff
Science: Davis, Heather ** Aug. 07 May. 12 Ph.D. Johnson
Pharmacotherapy & Egelund, Eric Aug. 09 May. 13 Ph.D. Peloquin
Translational Research Gonzalez, Daniel Aug. 08 May. 13 Ph.D. Derendorf
Jabarti, Hanaa * Aug. 11 May. 15 Ph.D. Hendeles
Karnes, Jason Aug. 08 May. 13 Ph.D. Cooper-DeHoff
Kawaguchi, Marina Aug. 10 May. 14 Ph.D. Frye
Moore, Mariellen Aug. 07 Dec. 12 Ph.D. Johnson
6
Table 2: Graduate Students in Residential Programs (cont.)
Department/Center Name Date Expected Degree
Mentor Entered Grad Date Sought
Pharmacotherapy & Shahin, Mohamed * Aug. 11 May. 15 Ph.D. Johnson
Translational Research Stanton, Melonie ** Aug. 06 May. 12 Ph.D. Frye
(cont.) Sultan, Abdullah * Aug. 11 May. 15 Ph.D. Peloquin
Pharmaceutical Outcomes Ali, Ayad Aug. 05 Dec. 12 Ph.D. Hartzema
and Policy Bird, Steven ** Aug. 10 May. 12 M.S. Hartzema
Canida, Lyle ** Aug. 10 May. 12 M.S. Winterstein
Douglas, Charles ** Aug. 05 Aug. 11 Ph.D. Ried
Eworuke, Efe Aug. 08 May. 13 Ph.D. Winterstein
Folmar, David ** Aug. 09 Dec. 11 M.S. Segal
Guo, Jennifer ** Aug. 08 Aug. 11 Ph.D. Hartzema
Hong, Evelyn ** Aug. 10 May. 12 M.S. Segal
Houtchens, Amy ** Aug. 10 May. 12 M.S. Kimberlin
Knox, Caitlin Aug. 09 May. 13 Ph.D. Winterstein
Lee, Christine Aug. 07 Dec. 12 Ph.D. Segal
Lester, Jean ** Aug. 10 May. 12 M.S. Lipowski
Linden, Stephan Aug. 07 Dec. 12 Ph.D. Winterstein
Liu, Wei Aug. 10 May. 14 Ph.D. Winterstein
Liu, Xinyue Aug. 10 May. 14 Ph.D. Winterstein
Ma, Qinli Aug. 07 Dec. 12 Ph.D. Kauf
Munoz, Monica Aug. 10 May. 12 M.S. Delaney
Murimi, Irene Aug. 10 May. 14 Ph.D. Kimberlin
Okoro, Olihe Aug. 09 May. 13 Ph.D. Odedina
Pepe, Salvatore ** Aug. 10 May. 12 M.S. Delaney
Pham, Hanah ** Aug. 10 May. 12 M.S. Kauf
Ritho, Jane Aug. 05 Dec. 12 Ph.D. Hartzema
Rosenthal, Rachel Aug. 09 May. 13 Ph.D. Segal
Schelfhout, Jonathan Aug. 09 May. 13 Ph.D. Hartzema
Seto, Tom * June. 11 Left Prog Ph.D. Kimberlin
Stojanovic, Danijela Aug. 10 May. 14 Ph.D. Smith & Delaney
VoQui, Jessica ** Aug. 10 May. 12 M.S. Winterstein
Vu, Hong ** Aug. 10 May. 12 M.S. Kimberlin
Wen, Xueron (Sharon) Aug. 08 May. 13 Ph.D. Hartzema
Pharmacodynamics Bruce, Erin Aug. 08 Dec. 12 Ph.D. Katovich
Dutta, Garima ** Aug. 06 May. 12 Ph.D. Liu
Feng, Xiaodi Aug. 07 Dec. 12 Ph.D. Keller-Wood
Haslach, Erica ** Aug. 06 Aug. 11 Ph.D. Haskell-Luevano
Kasper, James Aug. 06 Dec. 12 Ph.D. Peris
Liu, Yue Aug. 07 Dec. 12 Ph.D. Liu
MacFadyen, Kaley Ann * Aug. 11 May. 15 Ph.D. Peris
Pati, Dipanwita July. 10 May. 14 Ph.D. Frazier
Rathinasabapthy, Anandharajan June. 09 May. 13 Ph.D. Katovich
Schaub, Jay ** Aug. 07 Aug. 11 Ph.D. Haskell-Luevano
Sharma, Heera ** Aug. 06 Dec. 11 Ph.D. Liu
Tikamdas, Rajiv Harish July. 10 May. 14 Ph.D. Liu
Wang, Lei * Aug. 11 May. 15 Ph.D. Peris
Wang, Yunyang June. 09 May. 13 Ph.D. Ellis
* new students entering a graduate program during FY 11/12 ** students who graduated with an M.S. or Ph.D. during FY 11/12
7
Table 3: Graduate Student Demographics in Residential Programs
Gender Citizenship American Minority
US Foreign Black Hispanic Asian/Island
Pacific
Indian/
Alaskan
# % # % # % # % # % # % # %
Total/% 93 36 38.7% 57 61.3% 1 1.1% 2 2.2% 5 5.4% 1 2.8%
Male 38 40.9% 15 39.5% 23 60.5% 0 0.0% 1 2.6% 1 2.6% 1 6.7%
Female 55 59.1% 21 38.2% 34 61.8% 1 1.8% 1 1.8% 4 7.3% 0 0.0%
Table 4: Residential Graduate Students, Fellows, Visiting Scholars and Exchange Students
Department/Center Graduate
Students
Post-doctoral
Fellows
Visiting
Scholars
Exchange
Students
Medicinal Chemistry 14 11 0 4
Pharmaceutics 25 6 0 28
Pharmacodynamics 14 6 0 0
Pharmaceutical Outcomes and Policy 29 1 0 0
Pharmacotherapy & Translational Research 11 8 0 0
COLLEGE TOTAL 93 32 0 32
Table 5: GPA and Test Scores of Graduate Students in Residential Programs Class GPA GRE TOEFL TSE
Verbal Quant. Total
COLLEGE TOTAL (93)* 3.59 473 693 1213 97 85
FY 11/12 Class (12) 3.69 493 753 1245 99 N/A * numbers in parenthesis denote student population
Table 6: Post-doctoral Fellows, Scientists and Visiting Scholars Department/Center Name Mentor Home Country
Medicinal Chemistry Canal, Clinton Booth USA
Chen, Qi Yin Luesch China
Kim, Myong Sang Booth Korea
Liu, Yanxia Luesch China
McManis, James Bergeron USA
Ratnayake, Ranjala Luesch Sri Lanka
Sakhuja, Rajeev Booth India
Sintjago, Tania Booth USA
Villa, Nancy Booth Columbia
Zhang, Wei Luesch China
Canal, Clinton Booth USA
Pharmaceutics/Center for Jadhov, Manoj Hochhaus India
Drug Discovery & Center for Lu, Yuanqing Song China
Drug Interaction Research Sampath, Chetham Butterweck India
and Education Singh, Rajendra Derendorf India
Singh, Ravi Derendorf Canada
Xiling, Jiang Schmidt China
Pharmaceutical Outcomes and Policy Yang, Tsu-Hsuan Segal USA
8
Table 6: Post-doctoral Fellows and Visiting Scholars (cont.) Department/Center Name Mentor Home Country
Pharmacodynamics Hofmann, Mackenzie Frazier USA
Kabakov, Anatoli Frazier Russia
Li, Zhimin Peris China
Qi, Yanfei Katovich China
Shenoy, Vinayak Katovich India
Yao, Hua Haskell-Luevano China
Pharmacotherapy & Translational Dietrich, Eric Gums USA
Research/ Center for Elliott, Jennifer Sando USA
Pharmacogenomics McDonough, Caitrin Johnson USA
Mohamed, Mohamed E. Frye Egypt
Patel, Vinita Angaran USA
Smith, Carolyn Munyer USA
Vandell, Alexander Johnson USA
Wilcox, Alisa Taylor USA
PharmD/Ph.D. Students in Graduate Programs
The University of Florida, College of Pharmacy offers a Joint Doctor of Pharmacy (PharmD) and Doctor of Philosophy
(Ph.D.) Degree program for qualified Doctor of Pharmacy students who are interested in accelerated graduate studies. The
purpose of this program is to prepare clinically oriented pharmaceutical scientists. Through the selection of appropriate
graduate level courses and attainment of research skills and experience through research clerkships, students in the Doctor of
Pharmacy program can receive advanced standing in one of the graduate pharmaceutical science disciplines in the College of
Pharmacy. The joint degree program enables students to attain both degrees within a time frame of approximately nine years of
study from the beginning of college. This includes at least two years of prepharmacy studies, four years of professional
education, and approximately three to four years of graduate studies.
Due to the increasing interest from our PharmD students in the Clinical Pharmaceutical Sciences Program in our
Department of Pharmacotherapy & Translational Research and Department of Pharmaceutics, we have experienced a
resurgence of the PharmD/Ph.D. program in recent years. Our first student to complete the PharmD/Ph.D. track was in May
2005 in our POP Department. We have a total of 10 PharmD/Ph.D. students completing the joint degree program. Six students
have completed their PharmD curriculum and have now entered the Ph.D. program and 4 students are currently finishing their
PharmD degree and will enter the Ph.D. portion of the joint program in the next few years. A complete listing of
PharmD/Ph.D. students is listed in Table 7.
Table 7: PharmD/Ph.D. Students Engaged in COP Graduate Residential Programs
Student Name Department/Program
Expected Graduation Year
PharmD Ph.D.
Completed the Ph.D. Degree:
Heather Davis Pharmaceutics/PTR*/CST** 2007 2011
Melonie Stanton Pharmaceutics/PTR*/CST** 2006 2012
Completing the Ph.D. Degree:
Mariellen Moore Pharmaceutics/PTR*/CST** 2007 2012
Jason Karnes Pharmaceutics/PTR*/CST** 2008 2012
Daniel Gonzalez Pharmaceutics/PTR*/CST** 2008 2012
Eric Egelund Pharmaceutics/PTR*/CST** 2009 2013
Completing the PharmD Degree:
Nancy Gillis Pharmaceutics/PTR*/CST** 2012 2016
Donna Simpson Pharmaceutical Outcomes and Policy 2012 2016
Juan Hincapie-Castillo Pharmaceutical Outcomes and Policy 2013 2017
* PTR - Pharmacotherapy & Translational Research ** CST - Clinical Science Tract
9
FDA/CDER Students in the Master’s Program
This year was the fourth year of our graduate training program with FDA/CDER. Table 8 below lists students who
graduated in Spring 2012. Due to governmental budget constraints there will be no recruitment of students for the new
academic year.
Table 8: FDA/CDER Students in Master’s Residential Programs
Student Name Previous Institution Year Entered Program
Steven Bird Northeastern University 2010
Lyle Canida University of Florida 2010
Evelyn Hong University of Nebraska Medical Center 2010
Amy Houtchens University of Maryland Baltimore 2010
Jean Lester Lake Erie College of Osteopathic Medicine 2010
Monica Munoz Texas Tech University 2010
Salvatore Pepe Northeastern University 2010
Hanah Pham Hampton University 2010
Jessica VoQui Virginia Commonwealth University 2010
Hong Vu Palm Beach Atlantic University 2010
Graduate Student Recruitment Activities
Recruitment of graduate students was decentralized in 1991 and placed in the hands of the individual departments. As
such, departments are now responsible for their own recruitment brochures and strategies for graduate student recruitment.
Whenever possible, requests for application materials that come through the ORGS are now sent to the departments.
However, when applicants do not specify a graduate specialty in their letter of inquiry the ORGS handles these requests. To
streamline the process, a letter (see Appendix A) describing the individual graduate programs/specialties and identifying the
graduate coordinators of each graduate specialty is sent to each applicant. In this letter, applicants are encouraged to access
information from the COP home page on the Web.
Graduate student application activity for FY 11/12 for each of the departments is illustrated in Table 9. The College
received 238 completed applications. Of the 238 completed applications received by the departments, only 27 (or 11.3%) of
the applicants were accepted, of which 21 students (or 77.8% of the potential students) will enter our graduate programs for FY
12/13.
Table 9: Departmental Graduate Student Recruitment Activity
Department # Completed # Applications % # Applicants %
Applications Accepted Accepted Entered Entered
Medicinal Chemistry 74 6 6.8% 4 60.0%
Pharmaceutics 88 7 8.0% 5 71.4%
Pharmacodynamics 33 3 9.1% 3 100.0%
Pharmaceutical Outcomes and Policy 37 10 27.0% 8 80.0%
Pharmacotherapy & Trans. Research 7 2 28.6% 2 100.0%
COLLEGE TOTAL 238 27 11.3% 21 77.8%
Exchange Students in the College of Pharmacy
Each year many exchange students visit the COP for a 3-4 month period to help them develop in their research as part of
the core curriculum from their home country. Table 10 lists the 32 students hosted by the COP during this academic year.
10
Table 10: Exchange Students Department Student Name Mentor Home Country
Pharmaceutics/ Center for Drug Alfadhl, Salman Hochhaus Saudi Arabia
Discovery & Center for Drug Beck, Christian Derendorf Germany
Interaction Research and Education Burger, Gisela Derendorf Germany
Falcao, Nivea Derendorf Brazil
Gonzales, Sylvie Derendorf France
Habteab, Helen Derendorf Germany
Herlan, Laura Derendorf Germany
Hufendiek, Peter Derendorf Germany
Jadhav, Manoj Hochhaus India
Klein, Nadine Butterweck Germany
Krohne, Maren Butterweck Germany
Kremser, Eva Derendorf Germany
Lechavalier, Lucie Derendorf France
Panzovata, Giscardo Derendorf Italy
Raab, Annette Derendorf Germany
Richter, Christiane Butterweck Germany
Rolle, Vanessa Hochhaus Switzerland
Schilling, Damaris Butterweck Germany
Schwanke, Raquel Butterweck Brazil
Spahn, Saskia Derendorf Germany
Straub, Julie Derendorf Germany
Tavares Cavalcanti, Noely Derendorf Brazil
Volkner, Alexander Derendorf Germany
Wedler, Jonas Derendorf Germany
Wegmann, Sascha Derendorf Germany
Yu, Mingming Derendorf China
Zhang, Ruxue Butterweck China
Medicinal Chemistry Fuerst, Michael Luesch Germany
Ghaly, Peter James Egypt
Mievre, Quentin James France
Schneider, Jennifer James Germany
Pharmaceutical Outcomes and Policy Boteman, Lea Winterstein Germany
Graduate Student Graduation Activities
During this academic year the COP had 14 students finish their graduate program and earn a Ph.D. degree and 11 who
earned a Master’s degree. The following are the graduates according to commencement date.
Pharmaceutical Science Ph.D. Degrees Conferred
AUGUST 2011 (SUMMER COMMENCEMENT)
Name: Dr. Charles Allen Douglas
Dissertation Title: Towards an Operational Definition of Pharmacy Clinical Competency
Faculty Mentor: Dr. L. Douglas Ried, Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degree: B.S. in Business, University of Phoenix; MBA in Strategy, Peter F. Drucker Graduate School
of Management
Dr. Douglas assumed a position as an Assistant Professor in Pharmacy-Academic Support at Texas A&M University.
11
Name: Dr. Jennifer D. Guo
Dissertation Title: Random-effects Approaches Comparisons in Meta-analysis: Data Simulation with Binomial
Outcomes
Faculty Mentor: Dr. Abraham Hartzema, Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degree: M.S. in Pharmacology, Peking University; M.S. in Pharmaceutical Outcomes and Policy,
University of North Carolina at Chapel Hill
Dr. Guo assumed a position as a Pharmacoepidemiologist at UCB Biosciences, Inc., Raleigh, NC.
Name: Dr. Erica Haslach
Dissertation Title: Rational Drug Design Approaches Targeting the Mouse and Human Melanocortin Receptors
Faculty Mentor: Dr. Carrie Haskell-Luevano, Professor
Department: Pharmacodynamics
Previous Degree: B.S. in Chemistry, Shippensburg University
Dr. Haslach assumed a position as an Adjunct Chemistry Professor, Oklahoma City Community College.
Name: Dr. Kristen Merritt
Dissertation Title: Cloning and Characterization of Cytosolic Sulfotransferases from Channel Catfish Liver
Faculty Mentor: Dr. Margaret James, Professor
Department: Medicinal Chemistry
Previous Degree: B.S. in Chemistry, M.S. in Food Science and Human Nutrition, University of Florida
Dr. Merritt assumed a position as a Sr. Biological Scientist at Florida Biologix, Alachua, FL.
Name: Dr. Runa Naik
Dissertation Title: Pharmacokinetic Pharmacodynamic Characterization of JNJ-Q2, A Novel Fluoroquinolone
Faculty Mentor: Dr. Hartmut Derendorf, Distinguished Professor
Department: Pharmaceutics
Previous Degree: B.S. in Pharmacy, Rajiv Gandhi University of Health Sciences
Dr. Naik is currently looking for employment.
Name: Dr. Jay Schaub
Dissertation Title: Effects of Voluntary Exercise on the Central Melanocortin Receptor Knockout Mice
Faculty Mentor: Dr. Carrie Haskell-Luevano, Professor
Department: Pharmacodynamics
Previous Degree: B.S. in Chemistry, University of Florida
Dr. Schaub assumed a position as a High School Science Teacher, Gainesville High School, Gainesville, FL.
Name: Dr. Sean Travers
Dissertation Title: Characterization of the Molecular Determinants for Class A G Protein-coupled Receptor
Ligand Binding and Function: Drug Discovery Targeting the Histamine H1Receptor
Faculty Mentor: Dr. Raymond Booth, Professor
Department: Medicinal Chemistry
Previous Degree: B.S. in Chemistry, Elon University
Dr. Travers assumed a position as a Sales Associate at Anatom Technologies, Baldwin, MD.
Name: Dr. Manuela de Lima Toccafondo Vieira
Dissertation Title: Intravenous Microdialysis and Physiologically-based Pharmacokinetic Modeling as Tools to
Evaluate Pharmacokinetics and Drug-Drug Interactions
Faculty Mentor: Dr. Hartmut Derendorf, Distinguished Professor
Department: Pharmaceutics
Previous Degree: B.S. and M.S. in Pharmaceutical Sciences, Universidade Federal de Minas Gerais
Dr. Vieira assumed a position as a Post-doctoral Fellow with the Food and Drug Administration, Washington DC.
12
DECEMBER 2011 (FALL COMMENCEMENT)
Name: Dr. Matthias Fueth
Dissertation Title: In Vivo and In Vitro Protective Effects of Alpha-1 Antitrypsin on Doxorubicin-induced
Cytotoxicity
Faculty Mentor: Dr. Sihong Song, Associate Professor
Department: Pharmaceutics
Previous Degrees: Apotheker in Pharmacy, Technisch Universitaet Braunschweig
Dr. Fueth assumed a position as a Post-doctoral Fellow in the Department of Pharmaceutics, College of Pharmacy, University
of Florida.
Name: Dr. Heera Sharma
Dissertation Title: Cooperative Dopaminergic Neurotoxicity of Organochlorine Pesticides
Faculty Mentor: Dr. Bin Liu, Associate Professor
Department: Pharmacodynamics
Previous Degrees: B.S. in Pharmacy, Himalayan Pharmacy Institute; B.S. in Information Technology, Sikkim
Manipal University
Dr. Sharma assumed a position as a Post-doctoral Fellow in the Department of Pathology, College of Medicine, Case Western
Reserve University, Cleveland, OH.
MAY 2012 (SPRING COMMENCEMENT)
Name: Dr. Heather Marie Davis
Dissertation Title: Molecular Analysis and Pharmacogenetic Assessment of Calcium Signaling Pathway
Variation
Faculty Mentor: Dr. Julie Johnson, Professor
Department: Pharmacotherapy &Translational Research
Previous Degrees: PharmD, University of Florida
Dr. Davis assumed a position as a Pharmacist at CVS, Gainesville, FL.
Name: Dr. Garima Dutta
Dissertation Title: Dopaminergic Cystatin C: A Key Player in Neuron-microglia Interplay
Faculty Mentor: Dr. Bin Liu, Associate Professor
Department: Pharmacodynamics
Previous Degrees: B.S. in Pharmacy, Delhi Institute of Pharmaceutical Sciences and Research
Dr. Dutta assumed a position as a Post-doctoral Fellow in the Department of Neurobiology, School of Medicine, UCLA.
Name: Dr. Huong Le Moldthan
Dissertation Title: The Protective Effects of Plasma Gelsolin and Alpha 1-Antitrypsin on Ischemic Stroke
Outcome in Rats
Faculty Mentor: Dr. Sihong Song, Associate Professor
Department: Pharmaceutics
Previous Degrees: B.S. in Pharmacy, Hanoi College of Pharmacy; M.S. in Pharmaceutical Sciences, Utrecht
University
Dr. Moldthan is currently looking for employment.
Name: Dr. Melonie Stanton
Dissertation Title: Organic Anion-Transporting Polypeptide (OATP) Family: Contribution of Genetic Variation
and Botanical Interactions to Variability in Drug Disposition and Response
Faculty Mentor: Dr. Reginald Frye, Associate Professor
Department: Pharmacotherapy & Translational Research
Previous Degrees: PharmD, University of Florida
Dr. Stanton assumed a position as a Post-doctoral Fellow at Shands Hospital, Gainesville, FL.
13
Pharmaceutical Science Master’s Degrees Conferred
DECEMBER 2011 (FALL COMMENCEMENT)
Name: Mr. David Folmar
Faculty Mentor: Dr. Richard Segal, Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: B.S. in Pharmacy, Auburn University
Mr. Fulmar is continuing his active duty with the United States Air Force as a Pharmacy Consultant to the Department of
Defense Pharmacoeconomic Center, San Antonio, TX.
MAY 2012 (SPRING COMMENCEMENT)
Name: Dr. Steven Bird
Faculty Mentor: Dr. Abraham Hartzema, Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: PharmD, Northeastern University
Dr. Bird assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.
Name: Dr. Lyle Canida
Faculty Mentor: Dr. Almut Winterstein, Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: PharmD, University of Florida
Dr. Canida assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.
Name: Dr. Evelyn Hong
Faculty Mentor: Dr. Richard Segal, Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: PharmD, University of Nebraska Medical Center
Dr. Hong assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.
Name: Dr. Amy Houtchens
Faculty Mentor: Dr. Carole Kimberlin, Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: PharmD, University of Maryland Baltimore
Dr. Houtchens assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.
Name: Dr. Jean Lester
Faculty Mentor: Dr. Earlene Lipowski, Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: PharmD, Lake Erie College of Osteopathic Medicine
Dr. Lester assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.
Name: Dr. Monica Munoz
Faculty Mentor: Dr. Joseph C. Delaney, Assistant Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: PharmD, Texas Tech University
Dr. Munoz assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.
14
Name: Dr. Salvatore Pepe
Faculty Mentor: Dr. Joseph C. Delaney, Assistant Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: PharmD, Northeastern University
Dr. Pepe assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.
Name: Dr. Hanah Pham
Faculty Mentor: Dr. Teresa Kauf, Associate Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: PharmD, Hampton University
Dr. Pham assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.
Name: Dr. Jessica VoQui
Faculty Mentor: Dr. Almut Winterstein, Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: PharmD, Virginia Commonwealth University
Dr. VoQui assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.
Name: Dr. Hong Vu
Faculty Mentor: Dr. Carole Kimberlin, Professor
Department: Pharmaceutical Outcomes and Policy
Previous Degrees: PharmD, Palm Beach Atlantic University
Dr. Vu assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.
Forensic Sciences Master’s Degrees Conferred
This year in the Forensics Programs there were 497 students enrolled in one of the four Master’s programs and 182
students enrolled in one of the six certificate programs. Within the Master’s programs there was a total of 106 students who
graduated; 4 (3.8%) from the Drug Chemistry program, 34 (32.1%) from the DNA and Serology program, 56 (52.8%) from the
Forensic Science program, and 12 (11.3%) from the Pharmaceutical Chemistry program. Within the certificate programs there
was a total of 119 students who received their certificate; 8 (6.7%) from the Drug Chemistry program, 37 (31.1%) from the
DNA and Serology program, 20 (16.8%) from the Death Investigation program, 25 (21%) from Pharmaceutical Chemistry
program, 26 (21.9%) from the Forensic Toxicology program, 1 (0.8%) from the Clinical Toxicology program, and 2 (1.7%)
from the Environmental Forensics program. Listed in Table 11 are those students who have graduated with their Master’s in
one of the Forensic Sciences programs.
Table 11: Master’s Graduates in the Forensic Sciences Program Program Name
Summer 2011
DNA and Serology Arnold, David Cannon, Amory
Barkwill, Sharon Chang, Candice
Beamer, Vickie Fair, Elisa
Benvie, Sarah Guidry, Clair
Browder, Clare Peacock, Mary
Caceres, Gabriel
Drug Chemistry Boyd, Sarah Rowshan, Hooman
Lynn, Nicholas
Pharmaceutical Chemistry Miller, Rebecca Roberts, Bryce
Stultz, Megan Wilkinson, Robert
Forensic Science Biglin, Danielle Coleman, Scott
Braget, Amanda Hardin, Richard
Buccieri, Natalie Huene, Lauren
Bunker, Allison Jeko, Katie
Civil, Edward Klopcic, Sandra
15
Table 11: Master’s Graduates in the Forensic Sciences Program (cont.) Program Name
Summer 2011 (cont.)
Forensic Science (cont.) Marion, Monica Skinner, Brady
Mateu, Dania Smith, Sherry
Mizell, Kenyetta Tatarek-Adams, Elaine
Montoya, Oscar Toomer, Cicely
Mueller, Kyle Wisdom, Daniel
Parsons, Heather
Fall 2011
DNA and Serology Isherwood, Elaine Lease, Kristen
Johnson, Scott Scarpola, Jessica
Kerski, Anelle Tsangaras, Kyriakos
Kobayashi, Marie Wickersham, Alexis
Kurtzner, Christine
Pharmaceutical Chemistry Babos, Mary Beth Widden, Michael
Onimus, Matthew
Forensic Science Baughman, Seneca Laitinen, Fred
Black, Alan Lavine, Lawrence
Breen, Deborah Morris, Melissa
Crowetz, Robert Morrison, Glen
Gillaspie, Daniel Parr, Kathy
Heintz, Tyhra Rauch, Jene
Hendrickson, Elyse Rolnik, Rochelle
Hoza, Ashley Testa, Gina
Johnson, Kathleen Wunsch, Christina
Joseph, Karrel
Spring 2012
DNA and Serology Beach, Adam Lindley, Daniel
Casper, Nicole Naleid, Trevor
Corbin, Alisha Ramsey, Edward
Flint, Lauren Ramsi, Parisa
Grant, Rachel Setlak, Jennifer
Humphries, Brandon Sosebee, Ashleigh
Kasprzyk, Christine Whitson, Dustin
Drug Chemistry Hite, Breanne
Pharmaceutical Chemistry DiSante, Anne Marie Onsotti, Edward
Fesl, Adam Yoder, Carhyl
Kuipers, Joshua
Forensic Science Collie, Will Pulido, Desiree
Dill, Tonya Rautanen, William
Ernst, Erik Richardson, Kristie
Kazaros, Charles Rovensky, Joanne
Knox, Michael Showell, Megan
Kline, Jay Stamp, John
Kraul, Lauren Trainer, Benjamin
Messer, Brett Zecker, Lauren
Pharmacy Regulations and Policy Master’s Degrees Conferred
This year in the Pharmacy Regulation and Policy Program there were 172 students enrolled in one of the six programs
offered; Pharmacy Regulations and Policy, Applied Pharmacoeconomics, Clinical Research Regulation & Ethics, Patient
Safety & Risk Management, Drug Regulatory Affairs, and Institutional Pharmacy Leadership. Within the Master’s programs
there was a total of 53 students who graduated; 7 (13.2%) from the Pharmacy Regulation and Policy program; 26 (49.1%) from
the Applied Pharmacoeconomics program; 3 (5.7%) from the Clinical Research Regulations and Ethics program; 7 (13.2%)
from the Drug Regulatory Affairs program; 6 (11.3%) from the Patient Safety and Risk Management program; and 4 (7.5%)
16
from the Institutional Pharmacy Leadership program. Listed in Table 12 are those students who have graduated with their
Master’s in one of the Pharmacy Regulations and Policy programs.
Table 12: Master's Graduates in the Pharmacy Regulations and Policy Program Program Name
Summer 2011
Applied Pharmacoeconomics Philbin, Michael Steelman, Douglas
Rafi, John
Institutional Pharmacy Leadership Bell, Gabrielle Temple-Cooper, Mary
Patient Safety and Risk Management Buwe, Patrice
Pharmacy Regulations and Policy Berry, John
Fall 2011
Applied Pharmacoeconomics Charbonnet, Steve Lowry, Patrick
Hogan, Michael Walker-Fairclough, Jamie
Clinical Research Regulations and Ethics Wuerdeman, Erin
Drug Regulatory Affairs Benson, Amy Williams, Wayner
West, Kristin
Patient Safety and Risk Management Emery, Betty
Pharmacy Regulations and Policy Gilmore, Sheila Leonard, Melvin
Spring 2012
Applied Pharmacoeconomics Al-Najjar, Fouad Liao, Richard
Baird, Lisa Lok, Terence
Burford, Brian Patridge, Robert
Burttram, Roslyn Pruitt, Kevin
Carter, Jerrica Ramsey, Matthew
Crook, Shane Roman, Brian
Dauer, Stephanie Sepulveda, Michael
Harris, Michelle Zagadailov, Erin
Hawthorne, Hamilton Zelman, David
Hymel, Lisa
Clinical Research Regulations and Ethics Leinbach, Ashley Shah, Sweta
Drug Regulatory Affairs Aurand, Anelis Klaus, Kelly
Jain, Sumit Watson, Sharon
Institutional Pharmacy Leadership Poore, Michelle Simmons, Marrolyn
Patient Safety and Risk Management Bartlett, Robin Pinchevsky, Lyndsy
Hidalgo, Kathleen Smith, Tara
Pharmacy Regulations and Policy Garbutt, Brandi Vo, Bang
Marshall-Frank, Roxanne Yeske-Amato, Sharon
Graduate Student Funding and Awards
Awardees are recommended to the Graduate Studies Committee or the Executive Associate Dean for Research and
Graduate Studies by their respective graduate coordinator or departmental chair. Based on the student’s academic credentials
and letters of support, awardees are selected by the Executive Associate Dean for Research and Graduate Studies in discussion
with the Graduate Studies Committee.
The COP carried the major load of the funding of graduate student stipends by supporting 61 graduate student stipends;
eight students received support from extramural research grants; seven students were funded by their home government; and
eight students funded their own graduate education this year. Ten students received Grinter Awards as a supplement to their
state funding. Graduate stipends ranged from $14,400 to $25,750 with an average overall stipend of $18,358.
Nine graduate student fellowship proposals totaling $213,196 were submitted to extramural sources this year. Agencies to
which proposals were submitted were the American Foundation for Pharmaceutical Education (AFPE), Agency for Healthcare
Research and Quality (AHRQ), Pharmaceutical Research and Manufacturers of American Foundation, and PhRMA
Foundation.
17
Graduate School Fellowship
Beginning Fall Semester 1999, the University of Florida offered the Graduate School Fellowship program with the
express interest of increasing graduate enrollment and attracting high quality students to each graduate program at the
University. This fellowship represents the highest graduate student award available at the University and is funded at nationally
competitive levels starting at $22,500/year for four years plus all tuition remuneration, and full health insurance coverage. The
College of Pharmacy received five additional Graduate School Fellowships. The recipients of the Graduate School
Fellowships are:
Guanming Chen Pharmaceutics FY 11/12
Daniel Felsing Medicinal Chemistry FY 11/12
Tom Seto Pharmaceutical Outcomes and Policy FY 11/12
Mohamed Shahin Pharmacotherapy & Translational Research FY 11/12
Lei Wang Pharmacodynamics FY 11/12
Michelle Bousquet Medicinal Chemistry FY 10/11
Marina Kawaguchi Pharmacotherapy & Translational Research FY 10/11
Irene Murimi Pharmaceutical Outcomes and Policy FY 10/11
Dipanwita Pati Pharmacodynamics FY 10/11
Sherwin Sy Pharmaceutics FY 10/11
Bhargava Kandala Pharmaceutics FY 09/10
Jennifer Synovec Medicinal Chemistry FY 09/10
Yunyang Wang Pharmacodynamics FY 09/10
Greg Welder Pharmacotherapy & Translational Research FY 09/10
Lisa Zeigler Pharmaceutical Outcomes and Policy FY 09/10
Daniel Gonzalez Pharmacotherapy & Translational Research FY 08/09
Jason Karnes Pharmacotherapy & Translational Research FY 08/09
Krishnakanth Kondabolu Medicinal Chemistry FY 08/09
Kyle Lokuta Pharmacodynamics FY 08/09
Efe Odia Pharmaceutical Outcomes and Policy FY 08/09
Wan Sun Pharmaceutics FY 08/09
Fullbright Capes Scholarships
The CAPES Foundation is a Brazilian government agency awarding scholarship grants to graduate students at universities
and research centers in Brazil and abroad. Its central purpose is to coordinate efforts to improve the quality of faculties and
staff in higher education through its grant program. CAPES is particularly concerned with the training of researchers in
doctorate, pre-doctoral short-term research and post-doctorate scholar programs. At present CAPES supports about 22,000
students in Brazilian graduate programs and 1,500 in other countries. The recipient of the Fullbright Capes Scholarship is:
Manuela Vieira Pharmaceutics FY 07/08
Ruffolo Fellowship
The Robert & Stephany Ruffolo Graduate Student Fellowship is awarded to a senior Pharmacodynamics graduate
student who has demonstrated excellence in his/her graduate studies, including excellence in the classroom and in research,
publication of their research, presentation at national meetings, and commitment to a scientific career. This award consists of
an annual stipend supplement of $1,500. The awardee is selected by the faculty in Pharmacodynamics. The recipient of the
Robert & Stephany Ruffolo Graduate Student Fellowship is:
Erin Bruce Pharmacodynamics FY 08/09
Mary Kay Owens Fellowship
The Mary Kay Owens Fellowship is awarded to two graduate students each year in the Department of Pharmaceutical
Outcomes and Policy. One of the students selected must be working in conjunction with the Center for Medicaid with a focus
18
on analytical research, education and training in the areas of integrated, coordinated care models and technologies to promote
patient-centered, quality driven healthcare solutions. This award consists of an annual stipend of $20,000. The awardees are
selected by the faculty in Pharmaceutical Outcomes and Policy. The recipients of the Mary Kay Owen Fellowships are:
Stephan Linden Pharmaceutical Outcomes and Policy FY 10/11
Lily Ma Pharmaceutical Outcomes and Policy FY 10/11
DuBow Fellowship
The Lawrence J. DuBow Fellowship is awarded to a graduate student to support their research and education in the
Department of Pharmaceutical Outcomes and Policy, especially for students involved with research related to pediatrics. This
award consists of an annual stipend supplement of $5,000. The awardee is selected by the faculty in Pharmaceutical Outcomes
and Policy. The recipient of the DuBow Fellowship is:
Efe Odia Pharmaceutical Outcomes and Policy FY 10/11
Grinter Awards
Originated in 1988, the intent of the Grinter Awards program was to serve as a mechanism to recruit graduate students
with outstanding academic credentials into one of the College’s graduate programs. These awards come from monies allocated
from ORTGE on a college-by-college basis and supplement our existing state stipends, an additional $3,000 per year for a
maximum of 3 years ($9,000 total award). A statistical summary of the Grinter Awards in the COP is illustrated in Table 13.
Overall, we have had a 69.9% acceptance of Grinter Awards by prospective students. Sixty-three percent of the COP Grinter
Awardees have graduated from the COP program with either a Ph.D. or M.S. degree. The overall average GPA for the Grinter
Awardees is 3.52 with a GRE of 1224 and a TOEFL of 105.
Table 13: Statistical Summary of the Grinter Program – 1988 to Present
Statistic Overall % 11/12 Class
Total number offered 123 3
Total number accepted 86 69.9% 3
Total number graduated 54 62.8%
Total number still enrolled: past & present 20 23.3%
Number of active awardees 10 11.6% 3
Grade Point Average (GPA) 3.52 3.67
Graduate Record Exam -GRE (Verbal + Quant.) 1224 1157
Test of English as a Foreign Language (TOEFL) 105 N/A
This year the COP offered 3 new Grinter Awards. The recipients of the Grinter Awards are:
Sharvari Bhagwat Pharmaceutics FY 11/12
Kaley MacFadyen Pharmacodynamics FY 11/12
Guo Zhong Medicinal Chemistry FY 11/12
Erin Jackson Medicinal Chemistry FY 10/11
Xinyue Liu Pharmaceutical Outcomes and Policy FY 10/11
Danijela Stojanovic Pharmaceutical Outcomes and Policy FY 10/11
Rajiv Tikamdas Pharmacodynamics FY 10/11
Mongjen Chen Pharmaceutics FY 09/10
Caitlin Knox Pharmaceutical Outcomes and Policy FY 09/10
Rachel Rosenthal Pharmaceutical Outcomes and Policy FY 09/10
19
25th
Annual Research Showcase and Awards Recognition Day
A number of graduate students, post-doctoral fellows and professional students received cash awards and commemorative
plaques for participating in the COP “Annual Research Showcase and Awards Recognition Day”. The specifics of this
daylong event and the award winners are listed in ORGS Coordinated Events for the COP.
Graduate Student Awards and Recognitions
Olihe Okoro, a graduate student in the Department of Pharmaceutical Outcomes and Policy, received the 2012-2013 Faculty
for the Future Fellowship Award from the Schlumberger Foundation. This award will provide up to $50,000 towards her
dissertation which focuses on developing a conceptual framework for medication use among black women living with
HIV/AIDS in Florida, and a care process model for improved adherence, optimum retention and improved health outcomes in
this population. Olihe is also the recipient of a $750 scholarship of the 2012 Marilyn Little Scholarship from the
International Committee of Altrusa International of Gainesville.
Melonie Stanton, a graduate student in the Department of Pharmacotherapy & Translational Research, along with Drs. Karen
Sando, Randell Doty, and Jennifer Elliott, were selected to receive the 2012 American Association of Colleges of Pharmacy
(AACP) Innovations in Teaching Award for their project entitled “Medication Mysteries Infinite Case Tool”, an interactive
tool with game-like features that allows 2nd
year professional students to practice multiple patient interview scenarios in a lab
setting.
Professional Student Awards and Recognitions
Juan Hincapie-Castillo, a professional student at the Jacksonville campus, was appointed to the American Society of
Health-System Pharmacists (ASHP) Council of Therapeutics by the ASHP President for a one year term ending with the
ASHP Annual House of Delegates Session in June 2013.
Donna Rivera, a professional student at the St. Petersburg campus, received a $7,500 scholarship from the 2012 Phi Lambda
Sigma American Foundation for Pharmaceutical Education (AFPE) First Year Graduate School Fellowship in
Pharmaceutical Sciences.
International Student Academic Awards
At the International Student Academic Awards Ceremony held November 17, 2011, in the Reitz Union Auditorium, five
of the College of Pharmacy’s international graduate students received a certificate award for outstanding academic
accomplishment. The recipients of the International Student Awards are:
Daniela Conrado Pharmaceutics
Marina Kawaguchi Pharmacotherapy & Translational Research
Wei Liu Pharmaceutical Outcomes and Policy
Yue Liu Pharmacodynamics
Lilibeth Salvador Medicinal Chemistry
Graduate Minority Activities
The ORGS has continued to work with the Graduate School’s Office of Graduate Minority Programs (OGMP) in
recruiting minority students into the College’s graduate programs. The ORGS filters information down to individual
departments concerning funding opportunities for both graduate minority students as well as undergraduate minority students
interested in a research career.
Names of interested minority students were passed on to the respective departmental chairs or graduate coordinators by
Dr. Michael McKenzie, Associate Dean for Professional Affairs, following his various recruiting trips to colleges for our
professional program. Each Department then follows up with a letter and application packet to the student(s) outlining their
respective graduate program and its objectives.
Return to Table of Contents
20
Research Activities in the College of Pharmacy
Grant and Contract Efforts and Funding
Pharmaceutical research continues to be a major effort within the College of Pharmacy at the University of Florida.
According to the American Association of Colleges of Pharmacy (AACP) annual listing of Colleges of Pharmacy and their
placement relative to Schools of Pharmacy engaged in active pharmaceutical research, the University of Florida was ranked 18th
this past year out of 74 schools with research programs as seen in Table 14. These placements are based solely on fiscal year
NIH funding (October to September of a given year).
Table 14: AACP Statistics for NIH Funding
NIH NIH Rank FTE Ph.D.’s NIH Support/ Rank
Fiscal Year Support FTE- Ph.D.
2007 $4,959,305 20 35 $141,494 23
2008 $6,401,646 14 34 $188,284 15
2009 $6,081,908 19 34 $178,880 22
2010 $6,849,361 18 37 $185,118 22
2011 $7,399,403 18 15* $493,294* 18*
* in FY 2011 the AACP no longer reports funding data based on FTE PhD’s, Instead this year and all future years will be
reported based on the number of funded Principal Investigators.
Our faculty members continue to be productive and are making efforts to obtain more extramural support for their
individual research efforts. During this year the ORGS processed a total of 124 extramural grant or contract applications from
the five Departments for a total of $87,045,370 in new grant dollars, see Table 15. This is a 40.7% increase in total dollars
requested when compared to FY 10/11, see Table 16. The majority of new proposals (75.8%) within the COP are proposals in
which the Principal Investigator (PI) is a faculty member within the COP (Tables 15 and 16). Research faculty members are
also encouraged to collaborate with other units within the University. Twenty-four percent of grants submitted were originated
outside of the College of Pharmacy.
Table 17 shows total extramural research dollars brought into the College over the last five fiscal years (from July to June of
a given fiscal year). This year our research funding dollars totaled $8,983,763 with 99 individual awards coming into the
College of Pharmacy. This represents a decrease in total funding by 15.4% although the number of awards received was the
same compared to FY 10/11.
During FY 11/12 departmental comparisons show that Pharmacotherapy & Translational Research brought in the highest
total of research dollars within the COP at 45% ($4,045,279). Pharmacodynamics was second at 19.3% ($1,737,022); followed
by Medicinal Chemistry at 16.7% ($1,505.112); Pharmaceutical Outcomes and Policy at 10.2% ($913,075); and Pharmaceutics
at 8.8% ($787,275).
TOTAL EXTRAMURAL FUNDING to the COP is illustrated in Table 18. Total extramural support includes not only
RESEARCH funds (also found in Table 17) but also those ADMINISTRATIVE funds that included support for educational
training activities. This year there were no additional ADMINISTRATIVE funds. Overall, Total Extramural Funding had a
decrease of 15.4% from FY 10/12 (Tables 18 and 19).
21
Table 15: Proposal Processing Summary Department Inside the College Outside the College Total
College Total
# Proposals 94 30 124
Total Amount $81,939,431 $5,105,939 $87,045,370
Medicinal Chemistry
# Proposals 13 11 24
Total Amount $20,875,710 $2,124,676 $23,000,386
Pharmaceutics
# Proposals 18 5 23
Total Amount $36,218,255 $985,040 $37,203,295
Pharmacodynamics
# Proposals 11 4 15
Total Amount $6,286,667 $766,818 $7,053,485
Pharm. Outcomes & Policy
# Proposals 23 2 25
Total Amount $5,631,332 $167,260 $5,798,592
Pharm. & Translational Research
# Proposals 29 8 37
Total Amount $12,927,467 $1,062,145 $13,989,612 Inside the College = PI was a COP faculty member; Outside the College = PI was outside the COP; COP personnel were co-investigators
Table 16: Proposal Processing Comparison Fiscal Year Inside the College Outside the College Total
FY 10/11
# proposals 103 28 131
Total Amount $54,027,344 $7,833,071 $61,860,415
FY 11/12
# proposals 94 30 124
Total Amount $81,939,431 $5,105,939 $87,045,370
Inside the College = PI was a COP faculty member; Outside the College = PI was outside the COP; COP personnel were co-investigators
22
Table 17: Extramural Research Dollars - FY 07/08 to FY 11/12
Department 07/08 08/09 09/10 10/11 11/12
Average
07/08 - 11/12
% of Total
11/12
COLLEGE TOTAL $7,192,475 $8,807,502 $10,550,670 $10,621,827 $8,983,763 $9,231,247 100.00%
F&A $1,337,594 $1,669,551 $1,944,971 $2,374,018 $1,688,991 $1,803,025 100.00%
# grants 91 100 101 99 99 98
%F&A 22.8% 23.4% 22.6% 28.8% 23.2% 24.2%
Medicinal Chemistry $1,633,481 $2,333,801 $1,949,202 $2,685,604 $1,501,112 $2,020,640 16.71%
F&A $404,829 $486,631 $474,817 $539,078 $338,066 $448,684 20.02%
# grants 13 14 10 12 10 12
%F&A 32.9% 26.3% 32.2% 25.1% 29.1% 29.1%
Pharmaceutics $1,361,814 $1,297,192 $1,249,516 $1,327,201 $787,275 $1,204,600 8.76%
F&A $321,903 $272,091 $268,065 $298,882 $115,211 $255,230 6.82%
# grants 19 24 17 14 13 17
%F&A 31.0% 26.5% 27.3% 29.1% 17.1% 26.2%
Pharmacodynamics $963,262 $1,695,696 $1,422,553 $1,343,491 $1,737,022 $1,432,405 19.34%
F&A $262,392 $492,574 $403,359 $389,791 $502,161 $410,055 29.73%
# grants 9 18 15 14 18 15
%F&A 37.4% 40.9% 39.6% 40.9% 40.7% 39.9%
Pharm. Outcomes and Policy $321,697 $716,193 $1,189,754 $394,685 $913,075 $707,081 10.16%
F&A $72,864 $142,039 $81,474 $94,293 $56,126 $89,359 3.32%
# grants 5 2 11 11 12 8
%F&A 29.3% 24.7% 7.4% 31.4% 6.5% 19.9%
Pharm. & Trans. Research $2,912,221 $2,764,620 $4,739,645 $4,870,847 $4,045,279 $3,866,522 45.03%
F&A $275,606 $276,216 $717,256 $1,051,974 $677,428 $599,696 40.11%
# grants 45.0 42.0 48.0 48.0 46.0 46
%F&A 10.5% 11.1% 17.8% 27.5% 20.1% 17.4%
F&A = Facilities and Administrative Costs
Table 18: Total Extramural Support - FY 07/08 to FY 11/12
Dept.
07/08 08/09 09/10 10/11
Average
11/12 07/08-11/12
COLLEGE TOTAL $7,232,617 $8,928,374 $10,631,032 $10,621,827 $8,983,763 $9,279,523
F&A $1,350,704 $1,689,699 $1,944,971 $2,374,018 $1,688,991 $1,809,677
# grants 92 104 103 99 99 99.4
%F&A 23.0% 23.3% 22.4% 28.8% 23.2% 24.1%
RESEARCH $7,192,475 $8,807,502 $10,550,670 $10,621,827 $8,983,763 $9,231,248
F&A $1,337,594 $1,669,551 $1,944,971 $2,374,018 $1,688,991 $1,803,025
# grants 91 100 101 99 99 98
%F&A 22.8% 23.4% 22.6% 28.8% 23.2% 24.2%
ADMINISTRATION $40,142 $120,872 $80,362 $0 $0 $48,275
F&A $13,110 $20,148 $0 $0 $0 $6,652
# grants 1 4 2 0 0 1.4
%F&A 48.5% 20.0% 0.0% 0.0% 0.0% 13.7%
F&A = Facilities and Administrative Costs
23
Outlined below in Table 19 is a breakdown of the COP extramural support by sponsor type and number of awards for the
last two fiscal years. At 56.6%, just over half of the College’s extramural support comes from Federal Agencies. Federal dollars
were earmarked entirely for research purposes and showed a 23.7% decrease in dollars in spite of its 9.8% increase in the
number of awards this year from FY 10/11. State dollars decreased by half; Corporations and Companies showed an significant
increase of 108.3% in dollars received; and Foundation and Society monies also showed a considerable increase of 87.9% in
the dollars received compared to FY 10/11. The College experienced a decrease of 33.1% in funding within the “Other”
funding category from the previous year. Within this “Other” category are funds that include Miscellaneous Donor monies or
funds in which faculty members have unrestricted use to support their individual research programs.
Table 19: Comparison by Sponsor FY 10/11 FY 11/12
Sponsor Category # of awards Total Dollars # of Awards Total Dollars
Federal Agencies 51 $9,086,788 56 $6,930,207
Florida State Agencies 7 $683,868 4 $332,633
Corporations and Companies 28 $680,756 23 $1,417,711
Foundations and Societies 8 $156,360 13 $293,813
Other 5 $14,055 3 $9,400
Total Comparison 99 $10,621,827 99 $8,983,763
A more complete breakdown and two-year comparison of sponsor categories, number of awards and total dollars including
F&A costs can be seen in Tables 20-24. In Appendix B a complete listing of all extramural support by Department and
Faculty members can be found.
Table 20: Federal Agencies Comparison
FY 10/11 FY 11/12
Sponsor Count Total F&A Count Total F&A
AHCA 1 $323,025 $64,605 1 $192,650 $17,514
AHRQ 1 $192,015 $55,479 1 $25,379 $8,202
Food & Drug Administration 2 $1,000,000 $245,990 1 $539,114 $0
Natl Cntr for Dis Control & Prev 1 $22,500 $7,142
NIH 45 $7,530,511 $1,787,773 53 $6,173,064 $1,358,368
U.S. Department of Veteran Affairs 1 $18,737 $5,471
Total Federal Agencies 51 $9,086,788 $2,166,460 56 $6,930,207 $1,384,084 F&A = Facilities and Administrative Costs
Table 21: State Agencies Comparison FY 10/11 FY 11/12
Sponsor Count Total F&A Count Total F&A
Dept of Environmental Protection 1 $24,193 $4,839
Department of Health 7 $683,868 $75,603 3 $308,440 $39,604
Total Florida State Agencies 7 $683,868 $75,603 4 $332,633 $44,443 F&A = Facilities and Administrative Costs
24
Table 22: Corporations and Companies Comparison
FY 10/11 FY 11/12
Sponsor Count Total F&A Count Total F&A
Alnara Pharmaceuticals 1 $305 $61
AstraZeneca 2 $131,850 $37,550
Boehringer Ingelheim Intl GMBH 1 $100,000 $15,200 1 $6,800 $2,158
Clinical Research GMBH 1 $34,655 $3,150
FEFA INC 1 $309,202 $64,523
GlaxoSmithKline, Inc. 3 $122,174 $23,747 1 $30,759 $6,152
Golin-Harris Int'l., Inc. 1 $5,000 $1,000 1 $5,000 $1,000
Jacobus Pharmaceuticals 1 $73,371 $14,674 1 $192,043 $38,408
JMJ Technologies 1 $12,500 $2,500
Media Pharma GMB & CO KG 4 $70,296 $14,059 3 $110,421 $22,084
Merck - University of Texas 1 $57,475 $11,495
Micromedic Technologies 1 $38,500 $7,700
Novus International 1 $13,513 $2,703
Pfizer, Inc. 1 $200,000 $0
Phytolab GMBH & CO KG 1 $48,735 $9,747
Research Triangle Institute 1 $2,197 $200
Steigerwald Arzneimittelwerk 1 $14,988 $2,998
TKL Research 11 $183,022 $36,604 1 $5,750 $1,150
Watson Laboratories 7 $236,700 $47,340
Watson Pharmaceuticals 1 $87,060 $7,915
Wyle Laboratories 1 $6,151 $2,011
Total Corporations and Companies 28 $680,756 $126,643 23 $1,417,711 $249,486
F&A = Facilities and Administrative Costs
Table 23: Foundations and Societies Comparison
FY 10/11 FY 11/12
Sponsor Count Total F&A Count Total F&A
American Assoc. Colleges of Pharmacy 1 $8,820 $0
American Cancer Society 1 $11,493 $1,916 1 $11,492 $1,915
Am. Foundation for Pharmaceutical Edu. 2 $12,000 $0 6 $19,500 $0
American Heart Association 1 $22,180 $0 1 $77,000 $7,000
American Pharmacists Association 1 $1,000 $0
CHDI Foundation 1 $28,271 $0
Cystic Fibrosis Foundation 1 $1,500 $0
Society for Women's Health Research 1 $49,700 $0
UF Foundation 1 $93,260 $0 1 $100,000 $0
University of Colorado 1 $7,107 $646 1 $6,850 $623
Total Foundations and Societies 8 $156,360 $2,562 13 $293,813 $9,538
F&A = Facilities and Administrative Costs
Table 24: Other Comparison
FY 10/11 FY 11/12
Sponsor Count Total F&A Count Total F&A
Miscellaneous Donors 1 $300 $0 2 $2,200 $0
Multiple Sponsors 4 $13,755 $2,751 1 $7,200 $1,440
Total Other 5 $14,055 $2,751 3 $9,400 $1,440
F&A = Facilities and Administrative Costs
25
Clinical Laboratory Income
The Infectious Disease Pharmacokinetics Laboratory at the University of Florida (IDPL) has a clinical and research focus
on the treatment of patients with serious infections. The lab, which opened in July 2009 and located in the College of Pharmacy,
is part of the Emerging Pathogens Institute. The IDPL serves as a national reference center for the determination of serum
concentrations for the antimycobacterial, antifungal, and anti-HIV drugs, as well as linezolid. The lab also measures vitamin D.
The IDPL provides therapeutic drug monitoring to physicians and their patients, and it provides research study support to
investigators, using high-performance liquid chromatography and gas chromatography.
The clinical lab, working in cooperation with the Shands Clinical Laboratory, is CLIA licensed and College of American
Pathologists (CAP) Certified. This year’s clinical income had a decrease of 7.2% (Table 25).
Table 25: Clinical Laboratory Income FY 10/11 FY 11/12
$424,492 $393,565
Licensing and Royalty Income
Through licensing and maintenance fees the College of Pharmacy generated a total of $175,967 in revenues during FY
11/12. These monies were distributed to the College as outlined in the UF IP distribution policy.
Graduate Student Research Activities
Ayad Ali, a graduate student in the Department of Pharmaceutical Outcomes and Policy, was awarded a complimentary one-
year membership and a $1,500 travel award from the International Society for Pharmacoepidemiology (ISPE) for his poster
entitled “Inhaled and Intranasal Corticosteroids and Behavioral and Psychiatric Problems: A Pharmacovigilance Analysis
using AERS Data” to attend the 27th
ISPE in Chicago, IL in August 2011. Ayad also received a $750 travel award from the
American Association of Pharmaceutical Sciences (AAPS) for his poster entitled “Outcomes of Late Corticosteroid
Withdrawal after Renal Transplantation in Patients Exposed to Tacrolimus and/or Mycophenolate Mofetil: A Meta-
Analysis of Randomized Controlled Trials” to attend the 2011 AAPS Annual Meeting in Washington, DC in October 2011.
He also received a $500 student travel award from AAPS for his poster entitled “Association of Omalizumab with
Arteriothrombotic Events: A Pharmacovigilance Analysis” to attend the 2012 AAPS National Biotechnology Conference in
San Diego, CA in May 2012. He also received a $250 travel award from the University of Florida’s Graduate Student
Council for his poster entitled “Assessing the Association of Omalizumab Use and Arteriothrombotic Events through
Spontaneous Adverse Event Reporting” to attend the 17th
International Society for Pharmacoeconomics and Outcomes
Research (ISPOR) International Meeting in Washington, DC in June 2012.
Daniela Conrado, a graduate student in the Department of Pharmaceutics working with Dr. Hartmut Derendorf, was awarded
a $1,000 honorarium, a certificate, and complimentary registration from the American College of Clinical Pharmacology
(ACCP) for her abstract entitled “Population Pharmacokinetics and Pharmacodynamics of Armodafinil: Effects on
Electroencephalogram and Alertness of Sleep-deprived Adults” to attend the 40th
Annual Meeting of the ACCP in Chicago,
IL in September 2011. In addition, at the ACCP meeting Daniela competed for and won the Wayne A. Colburn Memorial
Award in which she receives an additional $500. Daniela also received a plaque and complimentary registration from the
American Society Clinical Pharmacology and Therapeutics (ASCPT) Presidential Trainee Award for her abstract
entitled “Pharmacokinetic-Pharmacodynamic Modeling for Armodafinil: Effects on Alertness and Electroencephalogram
of Sleep Deprived Adults” to attend the 113th
Annual Meeting of the ASCPT in National Harbor, MD in March 2012. In
addition, she also received $1,000 honorarium, a certificate, and complimentary registration from the American College of
Clinical Pharmacology (ACCP) for her abstract entitled “Pharmacokinetic-Pharmacodynamic Modeling of the
Electroencephalogram Effect of Armodafinil: Correlation with Behavioral Alertness” to attend the 41st Annual Meeting of
the ACCP in Hollywood, FL in October 2012.
Xiaodi Feng, a graduate student in Pharmacodynamics working with Dr. Maureen Keller-Wood, was awarded a Pfizer
President's Presenter's Award by the Society of Gynecologic Investigation for her abstract "Cortisol Increases Activated
Caspase-3 in Conductive Cells in the Fetal Heart" presented at the meeting in San Diego, CA in March of 2012. The award
consisted of a $1,000 award and a plaque, and was recognized at a luncheon at the Annual Meeting of the Society.
26
Caitlin Knox, a graduate student in the Department of Pharmaceutical Outcomes and Policy working with Dr. Almut
Winterstein, was awarded a $6,500 fellowship from the American Foundation for Pharmaceutical Education (AFPE) for
her project entitled “Type II Diabetes in Pregnant Women: Prevalence, Drug Utilization and Outcomes of Women with Type
II Diabetes during Pregnancy”.
Rana Montaser, a graduate student in the Department of Medicinal Chemistry working with Dr. Hendrik Luesch, was awarded
a $600 travel award from the American Society of Pharmacognosy (ASP) Waqar Bhatti Student Travel Award for her
paper entitled “Chemistry and Biology of Novel Cyanobacterial Secondary Metabolites from Guam” to attend the 2012
International Congress on Natural Products Research meeting in New York City, NY in July 2012.
Lilibeth Salvador, a graduate student in the Department of Medicinal Chemistry working with Dr. Hendrik Luesch, was
awarded the 2012 Kilmer Prize which consists of a $300 travel award from the American Pharmaceutical Association
(APhA) and a $700 travel award from the American Society of Pharmacognosy (ASP) for her paper entitled “Novel Elastase
Inhibitors from Marine Cyanobacteria: Structural Diversity, Target-bound Crystal Structures and Cellular Effects” to the
2012 International Congress on Natural Products Research meeting in New York City, NY in July 2012.
Jonathan Schelfhout, a graduate student in the Department of Pharmaceutical Outcomes and Policy working with Dr. Teresa
Kauf, was awarded a $6,500 fellowship from the American Foundation for Pharmaceutical Education (AFPE) for his
project entitled “Medication Adherence during Treatment for the Hepatitis C Virus: Impact on Sustained Virologic
Response Rates, Patient Burden and Lifetime Costs”.
Wan Sun, a graduate student in the Department of Pharmaceutics working with Dr. Gunther Hochhaus, was awarded a $1,000
honorarium, a certificate and complimentary registration from the American College of Clinical Pharmacology (ACCP) for
her abstract entitled “Development of a Disease Model for Bipolar Disorder” to attend the 2012 ACCP Annual Meeting in San
Diego, CA in September 2012.
Professional Student Research Activities
As the understanding of the development of new pharmaceutical agents and streamlining the drug use process is an integral
part of a pharmacy student’s education, the College of Pharmacy offers a series of “Problems in Pharmacy” courses that
expose students to various aspects of the research process. Each department in the College offers a “Problems in Pharmacy”
course that is designed to specifically target their individual research areas. In addition to the “Problems in Pharmacy”
courses, professional students interested in research select faculty mentors and submit grant or fellowship applications to
outside funding agencies to support their research efforts. This year we had 2 professional students who secured extramural
funding.
Julie Foster, a professional student at the Gainesville campus, received a $1,000 scholarship from the 2012 American
Association of Colleges of Pharmacy (AACP) Walmart Scholars Program to cover registration and travel expenses for the
Teacher’s Seminar to the AACP Annual meeting in Kissimmee, FL in July 2012.
The College of Pharmacy is dedicated to increasing the number of professionally trained pharmacists to consider a career
in academic pharmacy and pharmaceutical/biomedical research. We have found that providing an environment for training of
PharmD students very early in their professional degree program has been successful in directing future graduates to careers
in research. In following, the College provided a 10-week, full-time paid summer internship of $4,500 to both first (1PD)
and second (2PD) year PharmD students. The recipients of the summer internships are:
Student Name Campus Mentor
Meghan Arwood Gainesville Dr. Rhonda Cooper-DeHoff
Alan Beers Gainesville Dr. Margaret James
Bryan Brinda Gainesville Dr. John Markowitz
Sarah Burbage Gainesville Dr. Julie Johnson
Alan Byard Gainesville Dr. Charles Peloquin
Jacqueline Byrd Gainesville Dr. Julie Johnson
Lori Carter Gainesville Dr. Tommy Smith & Dr. Debbie Wilson
Melissa Chudow Gainesville Dr. Richard Segal
Juan Hincapie-Castillo Gainesville Dr. Almut Winterstein
Kenneth Leonard Gainesville Dr. Michael Katovich
Megha Patel Gainesville Dr. John Markowitz
27
Student Name Campus Mentor
John Prybyski Gainesville Dr. Ken Sloan
Priya Thoguluva Gainesville Dr. Earlene Lipowski
Sarah Valentine Gainesville Dr. Abraham Hartzema
Erika Walters Gainesville Dr. James Taylor
Krista White Gainesville Dr. David Angaran
Janis Dolembo Jacksonville Dr. John Lima
Petra Estep Jacksonville Dr. John Lima
Ronald Granados Orlando Dr. Rhonda Cooper-DeHoff
Mai-Thao Nguyen Orlando Dr. Otto Phanstiel
Rosemary Persaud Orlando Dr. Greg Roth
Scott Allen St. Petersburg Dr. P.K. Burnette
Richard Aramini St. Petersburg Dr. Joanna Peris
Danielle Honein St. Petersburg Dr. Reginald Frye
Jared Mannen St. Petersburg Dr. Julie Johnson
Lauren Self St. Petersburg Dr. Javier Cuevas
Return to Table of Contents
28
U.S.-Thai Consortium Activities
History of the U.S.-Thai Consortium
Until FY 08/09 the Executive Associate Dean also acted as the College’s principal liaison for the U.S.-Thai Consortium,
then Dr. Earlene Lipowski, Professor in the Department of Pharmaceutical Outcomes and Policy, assumed the US-Thai
consortium liaison position. This initiative is a major international training agreement between all of the colleges of pharmacy
in the country of Thailand and selected pharmacy schools in the United States.
In 1993, the University of Florida College of Pharmacy, nine other U.S. Pharmacy Schools and the American Association
of Colleges of Pharmacy entered into an international agreement with all nine (at that time) Thailand Colleges of Pharmacy
which together designated the U.S.-Thai Consortium Agreement. Since 1993, two other Thai schools and four U.S. schools
have joined the Consortium.
The mission of this U.S.-Thai agreement is to provide Thai pharmacists (faculty at the various Thai pharmacy schools),
that are selected by a Royal Thai Government Panel, the opportunity for advanced professional (Pharm.D.) or graduate (Ph.D.)
study in programs in the selected U.S. pharmacy schools. In return, the Royal Thai government will pay all stipend and tuition
costs for these students for a period of five years and provide return favors for both professional students and faculty to visit
Thailand and become involved in post-graduate pharmacy education abroad. Furthermore, the initial agreement was for the
Thai government to support, and the U.S. colleges to educate, 100 Thai faculty members (i.e., approximately 10 students per
U.S. college) over the ensuing 10 years.
As part of the original charter, it was agreed that all parties would meet once a year to discuss the progress of the U.S.-
Thai Consortium. These annual meetings would be held in either Thailand or the U.S. on alternating years. The first meeting
was held in Bangkok, Thailand in 1994; at Purdue University in 1995; at Phuket, Thailand in 1996; in Baltimore, MD in 1997;
Chiang Mai, Thailand in 1998; Orlando, FL in 2000; Bangkok, Thailand in 2002; Chicago, IL in 2004; Bangkok, Thailand in
2007; Madison, Wisconsin in 2008; and Phuket, Thailand in 2011.
Current List of Thai and U.S. Schools of Pharmacy in the Consortium
Thailand United States
1. Chulalongkorn University
2. Mahidol University
3. Khon Kaen University
4. Srinakharinwirot University
5. Prince of Songkla University
6. Silpakorn University
7. Ubon Ratchathani University
8. Chiang Mai University
9. Naresuan University
10. Mahasarakarn University
11. Rangsit University
12. Walailak University
1. University of Florida
2. Purdue University
3. Ohio State University
4. University of Wisconsin
5. University of Arizona
6. University of Minnesota
7. University of Illinois – Chicago
8. University of Maryland - Baltimore
9. University of North Carolina – Chapel Hill
10. University of Kentucky
11. University of Texas – Austin
12. University of Washington
13. University of Utah
14. University of Iowa
15. American Association of Colleges of Pharmacy
11th
U.S.-Thai Pharmacy Education Consortium Meeting
The biennial meeting of the U.S. – Thai Pharmacy Consortium was held June 1-4, 2011 in Phuket, Thailand with Prince of
Songkla University serving as the host institution.
There have been no new activities with the U.S.-Thai Consortium in the past year. Informal reports are that the Consortium
will meet next May in Baltimore, hosted by the University of Maryland. There is no official confirmation of a date. Dr.
Lipowski volunteered to serve on the planning committee for that meeting but has not had any further communication with the
steering committee.
Dr. Lipowski offered an APPE elective in International Health for 4 students during the month of June. Funding for this
was provided by a Faculty Enhancement Opportunity Award from UF and a complete report from Dr. Lipowski is available
upon request for those interested.
29
Thai Students in the College of Pharmacy
Listed below (Table26) is the Thai student enrolled during FY 11/12, although she is not the recipient of the Royal
Thai Scholarship from her government to study abroad for her Ph.D. degree.
Table 26: Thai Students
Name Department THAI Pharmacy College Date Entered
Metavarayuth, Kamolrat * Medicinal Chemistry Chulalongkorn University FY 10/11
* not a Royal Thai Scholar
Return to Table of Contents
30
ORGS Coordinated Events
Two major COP functions are coordinated by the ORGS, the Post-baccalaureate Reception and the Annual Research
Showcase and Awards Recognition Day. These events are described below.
Post-baccalaureate Reception
The annual Post-baccalaureate Reception is held at the beginning of the Fall Semester as an event to introduce all new
faculty, graduate students, post-doctoral fellows and research associates to the COP community. This year the event was held
on Wednesday, September 14, 2011, in the Grand Ballroom at the Reitz Student Union from 6:00 PM to 8:00 PM. This year we
had 141 faculty, staff and students. At the reception this year 12 new graduate students, 6 new faculty members, and a number
of new post-doctoral fellows, research associates and visiting scientists were introduced to the college.
Annual Research Showcase and Awards Recognition Day
The 25th
Annual Research Showcase and Awards Recognition Day took place on Thursday, February 16, 2012, at the
University of Florida, College of Pharmacy. A program booklet (Appendix C) is included that outlines the day’s events, a
complete list of competitors for each of the divisions and the judges for each of the events.
This year’s Showcase and Awards Recognition Day could not have taken place without the financial backing of our many
sponsors. Our major sponsors this year were Dr. Robert G. and Maria Bell (Ph.D. class of 1988) through Drug &
Biotechnology Development, LLC, Palm Harbor, FL; and Dr. James Talton (Ph.D. class of 1999) through Nanotherapeutics,
LLC, Alachua, FL. Other longtime supporters were Dr. Maureen McKenzie through DENALI BioTechnologies, Inc.,
Soldotna, Alaska; and Dr. Robert A. and Phyllis Levitt (Ph.D. class of 1961) of Boca Raton and Gainesville, FL sponsoring
the Levitt Division of the Oral Competition. For a complete list of our sponsors please refer to the program booklet.
The Showcase and Awards Recognition Day is full of excitement and discovery, as graduate students, pharmacy students
and post-doctoral fellows from throughout the College compete (via posters and platform presentations) for the distinction of
being the “best” in one of the following categories:
Oral Competition Poster Competition
Senior Graduate Division
Junior Graduate Division
Levitt Division
Post-doctoral Fellow Division
Pharmacy Student Division
Graduate Student Division
The finalists for the oral competition divisions submitted competitive abstracts that were reviewed and selected by the
Graduate Studies Committee within the College. The Senior Graduate Division of the Oral Competition applies to those
graduate students who are in the final stages of their graduate education. The Junior Graduate Division pertains only to
graduate students who are in the first two years of their graduate program. The Levitt Division was established in 1993 to
recognize those graduate students who are doing graduate work related in the areas of health outcomes research or related
translational research in the clinical sciences.
The finalists in each of the oral divisions give a 12-15 minute presentation followed by a 3-5 minute question/answer
period. Based on the student’s abstract and their presentation, a winner in each division is selected by a panel of judges.
Winners receive a $600 cash award and commemorative plaque. Each of the finalists receives a $300 cash award and a
commemorative plaque.
Judges for the oral competition were: Dr. Maureen McKenzie, Chief Executive Office, DENALI BioTechnologies, Inc.;
Dr. Maria Miralles, Senior Pharmaceutical Management Advisor, United States Agency International Development (USAID);
Dr. Robert Navarro, Clinical Professor, Department of Pharmaceutical Outcomes and Policy, College of Pharmacy; and Dr.
Larry Lopez, Emeritus Professor, Department of Pharmacotherapy & Translational Research, College of Pharmacy.
The winners of the oral competition are:
Senior Division – winner
Daniela Conrado Pharmaceutics $600 cash award
Title: “Pharmacokinetic-Pharmacodynamic Modeling of Armodafinil: Effects on Electroencephalogram and Neurocognition
of Sleep Deprived Adults”
Senior Division – finalists
Yue Liu Pharmacodynamics $300 cash award
Title: “Involvement of Mitochondrial Complexes in Divalent Manganese-stimulated Release of Hydrogen Peroxide
in Microglial Cells”
31
Rui Wang Medicinal Chemistry $300 cash award
Title: “Biological Mode of Action Study of a Small Molecule Inducer of the Antioxidant Response Element”
Junior Division – winner
Rana Montaser Medicinal Chemistry $600 cash award
Title: “Drugs from the Sea: Chemical and Biological Characterization of Novel Fatty Acid Derivatives from the Guamanian
Marine Cyanobacteria Lyngbya spp.”
Junior Division – finalists
Bhargava Kandala Pharmaceutics $300 cash award
Title: “Design and Analysis of Pharmacodynamic Crossover Studies Conducted to Establish Bioequivalence of Inhaled
Corticosteroids”
Lilibeth Salvador Medicinal Chemistry $300 cash award
Title: “Novel Bioactive Natural Products from the Marine Cyanobacterium Symploca sp. as Leads for Drug Discovery”
Levitt Division – winner
Steven Bird Pharmaceutical Outcomes and Policy $600 cash award
Title: “Risk of Venous Thromboembolism with Drospirenone: A Population-based Comparative-safety Study”
Levitt Division – finalist
Efe Eworuke Pharmaceutical Outcomes and Policy $300 cash award
Title: “Drug Utilization Patterns for Routine Therapies in Patients with Cystic Fibrosis”
For the poster competition this year we had 31 posters from graduate students, professional students and post-doctoral
fellows on display in the Reception Area of the Health Profession, Nursing and Pharmacy Building (HPNP). The posters were
manned between 9:30 AM and 11:30 AM when individual judging took place. The winners in each of the divisions received a
$300 cash award and a commemorative plaque.
The poster judges were: Dr. Abdolreza Davoodi-Semiromi, Research Assistant Professor, Department of
Pharmacotherapy & Translational Research, College of Pharmacy; Dr. Eric Krause, Assistant Professor, Department of
Pharmacodynamics, College of Pharmacy; Dr. Larry Lesko, Professor, Center for Pharmacometrics & System Pharmacology,
College of Pharmacy; Dr. Michael Philbin, Senior Clinical Science Manager, Abbott; Dr. Teresa Roane, Clinical Assistant
Professor, Department of Pharmacotherapy & Translational Research, College of Pharmacy; Dr. Stephan Schmidt, Assistant
Professor, Center for Pharmacometrics & System Pharmacology, College of Pharmacy.
The winners of the poster competition are:
Graduate Student Division – winners
Mong-Jen Chen Pharmaceutics $300 cash award
Title: “A Novel Approach of Regenerative Medicine for the Treatment of Alpha 1 Antitrypsin Deficiency”
Krishnakanth Kondabolu Medicinal Chemistry $300 cash award
Title: “Preclinical Antipsychotic Efficacy of Novel Phenylaminotetralin (PAT) Analogs Acting at Serotonin 5-HT2 Receptors”
Professional Student Division – winner
Joseph Pardo Shands at the University of Florida $300 cash award
Title: “Analysis of the Time-to-Positivity of Blood Cultures at a Tertiary Care Hospital: Antimicrobial Stewardship
Implications”
Post-doctoral Fellow Division – winner
Caitrin McDonough Pharmacotherapy and Translational Research $300 cash award
Title: “Non-synonymous SNPs in SELE, SELP, and SIGLEC12 Associated with Cardiovascular (CV) Outcomes in the
INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES)”
Return to Table of Contents
32
Other ORGS Activities
In addition to the two major functions coordinated by the ORGS (Post-baccalaureate Reception and the Annual Research
Showcase and Awards Recognition Day) other activities were performed or attended by ORGS personnel as outlined below.
Committee Assignments
The Executive Associate Dean served on various College, Health Science Center and University Committees throughout
the academic year.
Critical this year was the Executive Associate Dean’s role on the committee involved in the design and planning of the
new University of Florida Research and Academic Center (UFRAC) at Lake Nona, Florida. The UF Research and Academic
Center opened in the Summer of 2012 and features three main components critical to the College’s mission that are outlined in
the recent review by Linda Homewood, News and Communications Director in the College of Pharmacy:
Lake Nona Update - The University of Florida Research and Academic Center Orlando_July2012.docx
COLLEGE COMMITTEES
Executive Council: This committee met each month throughout the year to discuss relevant issues related to the daily
operations of the College and long-range planning. Chaired by the Dean of the College, this committee is integral to
assisting the Dean in making decisions on major initiatives in the College.
Graduate Studies Committee: Please see Graduate Education and Program Activities; Graduate Studies
Committee (GSC) Activities for details and activities of this committee throughout the year.
College Research Committee: The Executive Associate Dean serves as chair of the College Research Committee. The
research committee was established to prepare a written policy document on allocation and reallocation of research and
office space, as well as, critical review and direction of all research activities in the College. The committee is also a
decision making committee on “limited application programs”. Sponsors are restricting the number of applications an
institution can submit in response to many funding opportunities. The Research Committee will be involved in
selecting the proposal (or proposals) that will be submitted in response to a limited application program back to
the Division of Sponsored Research for selection at the University level. The Committee also selects college
finalists for the various research awards offered through the University.
Faculty Governance Council: The Executive Associate Dean serves as a non-voting ex-officio member of the Faculty
Governance Council. The Faculty Governance Council (FGC) is comprised of faculty and college administration, who
together make policies relevant to the faculty. The FGC met nine times this past year.
HEALTH SCIENCE CENTER (HSC) COMMITTEES
HSC Research Dean’s Group: This committee met monthly throughout the year to discuss relevant issues related to both
basic and clinical research within the HSC and University.
Anatomical Specimen Task Force: This committee met twice throughout the year to consider current and future policies
and use of cadavers and human specimens within the HSC teaching facilities.
HSC Traffic and Parking Task Force: This committee met four times throughout the academic year to consider issues
and establish policies related to parking and traffic patterns in and around the HSC.
UNIVERSITY COMMITTEES
Council of Graduate Deans: This committee met once per semester during the academic year and was entrusted with
making recommendations on major initiatives related to graduate education. The chair of this committee was Dr. Kenneth
Gerhardt, Associate Dean for Graduate Programs.
Land Use Facilities Planning Committee: The Executive Associate Dean d this past year served as the Chair of the
Committee. This committee met monthly to provide recommendations to UF entities related to policies related to UF land
use and facilities development. The breadth of this committee considered the land use for new building sites as well as
33
planning for proposed renovation of existing buildings. Our charge was to also assist in the development and updating of
the UF Master Plan related to land and building use.
Academic Infrastructure Council: As chair of the Land Use and Facilities Planning Committee the Executive Associate
Dean is also a member of the Senate’s Academic Infrastructure Council. This council's area encompasses the University's
infrastructure supporting the University's academic mission, including the provision of physical facilities and other physical
resources; libraries; information technology; the campus master plan; and the availability of adequate computer, classroom,
laboratory and other resources. This Committee met monthly throughout the Fall and Spring Semesters of 2011-2012.
Conferences Attended Related to ORGS and COP Activity
COP National Advisory Board: The Executive Associate Dean attended the Fall 2011 (September) and Spring
2012(April) National Advisory Board Meetings.
AACP Interim Meeting: The Executive Associate Dean attended the 2012 AACP Interim Meeting in San Diego, CA,
from February 11th
to February 15th
, 2012.
AACP Annual Meeting: The Executive Associate Dean attended the 2012 AACP Annual Meeting in Kissimmee, FL,
from July 14th
to July 18th
, 2012.
NCURA Departmental Research Administration Workshop: The Grants Specialist and the Sr. Grants Specialist
attended the NCURA DRA Workshop held on campus from September 19th
to September 21st, 2011.
SRA International Meeting: The Grants Specialist attended the 2011 Annual Society of Research Administrators (SRA)
International Meeting in Montréal, Canada from October 23rd
to October 26th
, 2011.
Return to Table of Contents
34
Appendices
Section
A = Letter to Graduate Applicants
B = Complete Listing of Extramural Support by Department and Faculty
C = 25th
Annual Research Showcase and Awards Recognition Day Booklet
Return to Table of Contents
35
College of Pharmacy 101 S. Newell Drive, HPNP Building, Room 4320 Office of Research and Graduate Studies PO Box 100484, Gainesville, FL 32610 Ph: 352-273-6308, Fax: 352-273-6306 Dear Applicant:
Thank you for your interest in graduate education in the College of Pharmacy at the University of Florida. The College of Pharmacy
currently has four major areas of graduate concentration. These areas include Medicinal Chemistry, Pharmaceutics, Pharmacodynamics
and Pharmaceutical Outcomes and Policy. In your letter you did not indicate which graduate area(s) of study you are interested in.
We ask at this time that you please specify your area of research concentration. In doing this you would certainly expedite the application
process and minimize the receipt of extra information about areas of research you have no interest in.
All College of Pharmacy graduate programs can be accessed on the World Wide Web (http://www.cop.ufl.edu). Using the WWW you
would get a comprehensive review of the underlying theme of each of our graduate programs as well as the faculty and their research
interests. Furthermore, you can download all application and admission forms for graduate study at the University of Florida from this web
site. I strongly encourage you to utilize this source of information (WWW), as this is your most efficient mechanism to apply to one or
more of the graduate programs in the College of Pharmacy.
In the event that you do not have access to the WWW, listed below is each of the Graduate Programs in the College of Pharmacy. We have
included a short overview of the area of graduate concentration with the name, address, phone number and e-mail address of the respective
graduate coordinator.
Graduate Program in Medicinal Chemistry
Medicinal Chemistry is a unique blend of the physical and biological sciences. The scope of the field is sufficiently broad to give students
with many different science backgrounds a rewarding and challenging program of study. Areas of active research include natural products,
chemistry, drug delivery systems, organic synthesis of medicinal agents, metal chelate design, drug metabolism, molecular toxicology,
molecular biology, analytical and forensic chemistry, molecular modeling and drug discovery. The department has excellent facilities for
research in the major areas of Medicinal Chemistry and faculty have been highly successful in attracting extramural research support for the
past several years.
Graduate Coordinator: Dr. Raymond Bergeron
Department of Medicinal Chemistry
PO Box 100485
College of Pharmacy, University of Florida
Gainesville, Florida 32610-0485
(352) 273-7726, E-mail: [email protected]
Graduate Program in Pharmaceutics
Research in the Pharmaceutics Department encompasses basic, applied, and clinical investigations in (i)
pharmacokinetics/biopharmaceutics, (ii) pharmaceutical analysis, (iii) pharmaceutical biotechnology and drug delivery. In addition to
teaching, all faculty members are involved in collaborative research projects with clinical and other basic scientists with the Health Center
or on campus. Many maintain collaborative ties with scientists in other universities and the pharmaceutical industry worldwide.
Graduate Coordinator: Dr. Tony Palmieri
Department of Pharmaceutics
PO Box 100494
College of Pharmacy, University of Florida
Gainesville, Florida 32610-0494
(352) 273-7868, E-mail: [email protected]
Training Program in Clinical Pharmaceutical Sciences
The Clinical Pharmaceutical Sciences training program is a collaborative effort between the Departments of Pharmacotherapy &
Translational Research and Pharmaceutics. The goal of the Clinical Pharmaceutical Sciences training program is to prepare
motivated individuals to pursue independent research careers in academia, industry, or government. The current research focus
of the program is on understanding genetic and non-genetic factors that contribute to variability in drug response. Selected areas
of research include cardiology, infectious disease, asthma/pulmonary, psychiatry, and clinical pharmacology/drug metabolism.
36
Students in the program conduct hypothesis-driven clinical research that includes a strong laboratory element. Excellent
research facilities are available including state-of-the art bioanalytical and pharmacogenomics laboratories, and an NIH-funded
Clinical and Translational Science Institute for clinical study conduction.
Graduate Coordinator: Dr. Reginald F. Frye
Department of Pharmacotherapy & Translational Research
Box 100486
College of Pharmacy, University of Florida
Gainesville, Florida 32610-0486
(352) 273-5453, E-mail: [email protected]
Graduate Program in Pharmaceutical Outcomes and Policy
Drug therapy is the most widely used and efficacious treatment modality available for a variety of health disorders. However, problems
(inappropriate prescribing, inadequate monitoring, and misuse of medication) with medication use are persistent and costly. Research and
course of study in the Department of Pharmaceutical Outcomes and Policy focuses on various issues related to societal use of medications
and include (i) estimating costs of drug-related morbidity and mortality, (ii) evaluating the prescribing process, medication use and related
health care activities and, (iii) examining ways to improve prescribing and use of medications in various health care systems.
Graduate Coordinator: Dr. Almut Winterstein
Department of Pharmaceutical Outcomes and Policy
PO Box 100496
College of Pharmacy, University of Florida
Gainesville, Florida 32610-0496
(352) 273-6258, E-mail: [email protected]
Graduate Program in Pharmacodynamics
The purpose of the graduate program in Pharmacodynamics is to develop biomedical scientists with a broad knowledge in the areas of
Physiology, Pharmacology, Endocrinology and Toxicology. Although the research interests of the faculty are broad, there is an emphasis
on the holistic approach to drug actions in living systems. The Department has strong programs in the areas of cardiovascular, reproductive
and neuroendocrine physiology and pharmacology, temperature regulation, neurobiology of aging, autonomic pharmacology, and
neuropharmacology.
Graduate Coordinator: Dr. Joanna Peris
Department of Pharmacodynamics
PO Box 100487
College of Pharmacy, University of Florida
Gainesville, Florida 32610-0487
(352) 273-7688, E-mail: [email protected]
Please direct any future questions or request for application materials concerning the area of study you are interested in to the graduate
coordinator of the respective department listed above.
If we can be of further assistance to you please call us at (352) 273-6301. Again, thank you for your interest in our college at the
University of Florida. We look forward to hearing from you and eventually, receiving your application forms.
Respectfully, Respectfully,
William J. Millard, Ph.D. José Ortiz
Executive Associate Dean Office Assistant
University of Florida University of Florida
College of Pharmacy College of Pharmacy
Return to Table of Contents
37
Complete Listing of Extramural Support in the COP for FY 11/12
MEDICINAL CHEMISTRY
Faculty Amount Number Agency Project Title
Raymond Bergeron $625,942 1 National Institute of Health Iron Chelators Predicated on Desferrithiocin
Raymond Booth $172,795 1 National Institute of Health Novel Functionally-selective Serotonin 5HT2 Drugs for Amphetamines
Abuse/Disorders
$231,282 1 National Institute of Health Serotonin 5HT2C Agonist Drugs with 5HT2A/SB Antagonist Activity
Margaret James $24,193 1 University of South Florida Effect of Deepwater Horizon Oil Spill on Fish Communities
$50,682 1 National Institute of Health Fetal Endocrine Disruption by Tryclosan
$37,261 2 National Institute of Health Seafood Hydrocarbon Residues & Coastal Community Health Risks (Project 3)
Hendrik Luesch $202,454 1 Florida Department of Health Chemistry and Biology of Apratoxins
$51,151 1 National Institute of Health Mitochondrial Oxidative Stress in the Retinal Pigment Epithelium as a Model for
Atrophic Macular Degeneration
Kenneth Sloan $105,352 1 University of Colorado Transcleral Therapeutics in Diabetic Retinopathy
38
PHARMACEUTICS
Faculty Amount Number Agency Project Title
Veronika Butterweck $4,542 1 National Institute of Health Herb-drug Clucuronidation Interactions
Hartmut Derendorf $6,800 1 Boehringer Ingelheim Intl GMBH Comparative Dissolution Study of Commercial Telmisartan Tablets
$6,500 2 American Foundation for
Pharmaceutical Education
Use of Dermal Microdialysis to Evaluate the Effect of Skin Properties and Application
Site on the Topical Bioequivalence of Diclofenac
$5,000 1 Golin-Harris International Inc. Grapefruit-Drug Interactions
$131,850 2 Astrazeneca In vitro PK/PD Investigations of Beta-Lactam/Beta-Lactamase-Combinations for the
Treatment of Infections caused by Multidrug Resistant Gram-negative Bacteria
$200,000 1 Pfizer, Inc. Pfizer Graduate Fellowship Award
Guenther Hochhaus $28,271 1 CHDI Foundation Development of Disease Progression Models for Huntington's Disease
$1,200 1 Miscellaneous Donors Miscellaneous Donors
$309,202 1 FEFA INC Pharmacokinetic Comparison of Locally Acting Inhaled Drug Products
$87,060 1 Watson Pharmaceuticals Stability of Methacholine Solutions at Room Temperature
Sihong Song $6,850 1 University of Colorado Structure Guided Small Molecule Targeting of Anti-insulin Primary Trimolecular
Complexes
39
PHARMACODYNAMICS
Faculty Amount Number Agency Project Title
Jason Frazier $183,125 1 National Institute of Health CB1R Independent Effects of Cannabinoids on Synaptic Physiology in the CNS
$100,000 1 University of Florida Foundation The Role of Calcium Activated Potassium Channels in Geriatric Memory Dysfunction
Michael Katovich $272,041 2 National Institute of Health Angiotensin-Converting Enzyme2 in Vascular Endothelial Function
$191,754 2 National Institute of Health CVD Protection Mechanisms Involving ACE2/ANG-(1-7)
Maureen Keller-Wood $120,015 2 National Institute of Health Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in Art
$238,777 2 National Institute of Health Effects of Maternal Cortisol on Fetal and Neonatal Growth and Metabolism
$13,874 1 National Institute of Health Fetal Endocrine Disruption by Tryclosan
$28,164 2 National Institute of Health Glucocorticoids, Stress and Blood Pressure Regulation
$13,722 1 National Institute of Health Paraventricular Nucleus Regulatory Mechanisms in Stress and Hypertension
$21,956 1 National Institute of Health Renal Transporters and Fetal Neuroendocrinology
$227,595 1 National Institute of Health The Baroreflex in Pregnancy: Effects of Adrenal and Placental Steroids
Eric Krause $248,999 1 National Institute of Health Central Angiotensin Receptors and the Neural Control of Homeostasis
Vinayak Shenoy $77,000 1 American Heart Association Therapeutic Role of ACE2 in Pressure-overload Induced Right Ventricular Dysfunction
and Failure
40
PHARMACEUTICAL OUTCOMES AND POLICY
Faculty Amount Number Agency Project Title
Chris Delaney $34,848 1 University of Washington Comparative Effectiveness of Lipid Lowering and Antihypertensive Medications among
Patients Infected with HIV
Teresa Kauf $30,759 1 GlaxoSmithKline The Burden of Hepatitis C-related Thrombocytopenia: Evidence from National Health
& Wellness Survey and Thrombocytopenia Survey
Folakemi Odedina $10,340 1 National Institute of Health Cancer Advocacy for African Countries
$65,986 1 Florida Department of Health Florida Community Health Workers Effectiveness Project
$1,000 1 Miscellaneous Donors Miscellaneous Donors
Richard Segal $6,500 2 American Foundation for
Pharmaceutical Education
Increasing Community Pharmacists Smoking Cessation Counseling Rate through
Professional Moral Engagement
Almut Winterstein $192,650 1 Florida Medical Quality Assurance Agreement between Florida Medical Assurance, Inc., and the Board of Trustees
$25,379 1 Rutgers State University Developing Evidence to Inform Decisions about Effectiveness Research Network
$6,500 2 American Foundation for
Pharmaceutical Education
Type II Diabetes in Pregnant Women: Prevalence, Drug Utilization and Outcomes of
Women with Type II Diabetes during Pregnancy
$539,114 1 Food and Drug Administration Pharmaceutical Outcomes and Policy Training Program for Health Science Graduates
41
PHARMACOTHERAPY & TRANSLATIONAL RESEARCH
Faculty Amount Number Agency Project Title
Rhonda Cooper-DeHoff $49,700 1 Society for Women's Health Research Sex-specific Genetic Variability in Mechanistic Pathways and Cardiovascular
Outcomes in Women with Non-obstructive Coronary Artery Disease
$29,139 1 Wake Forest University Women's Health Initiative Extension 2010-2015
Reginald Frye $242,392 2 National Institute of Health Herb-drug Clucuronidation Interactions
$11,492 1 American Cancer Society Mechanisms Predicting Pain Trajectory among Cancer Patients
Leslie Hendeles $5,750 1 TKL Research A Multi-center, Randomized, Double-blind, Five-way Crossover, Pharmacodynamic
Study Comparing Perrigo's Albuterol Inhalation Aerosol to Teva's ProAir HFA
Inhalation Aerosol using a Methacholine Challenge Design in Asthmatic Patients
$236,700 7 Watson Laboratories Double-blind, Double-masked, Randomized, Placebo-controlled, Cross-over Study of
the Bronchoprotective Effect of Generic Levalbuterol Tartrate HFA & Xopenex HFA
Metered-dose Inhaler Formulations against Methacholine-induced Bronchoconstriction
in Asthmatic Subjects
$110,421 3 MEDA Pharma GMBH & CO KG Relative Potency of Formoterol Novolizer 12 mcg Compared to Formoterol Aerolizer
12 mcg in Patients with Stable Asthma using a Bronchoprovocation with Methacholine
as a Bioassay
Julie Johnson $58,825 9 University of Pennsylvania Clarification of Optimal Anticoagulation through Genetics (COAG)
$29,984 1 Ohio State University Expression Genetics in Drug Therapy (AIMS 3-5)
$1,780,582 1 National Institute of Health Pharmacogenomic Evaluation of Antihypertensive Responses
$87,900 1 University of Maryland Pharmacogenomics of Anti-platelet Interventions-2 (PAPI2) Study
$708,555 2 National Institute of Health Secondary Prevention of Subcortical Stroke Prevention Genetic Substudy
$130,230 2 National Institute of Health UF Clinical and Translational Science Award
$7,425 1 Cedars Sinai Medical Center Women’s Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction
42
PHARMACOTHERAPY & TRANSLATIONAL RESEARCH (cont.)
Faculty Amount Number Agency Project Title
Taimour Langaee $6,151.00 1 Wyle Laboratories Genotyping Analysis
$38,500 1 Micromedic Technologies Pharmacogenetic and Clinical Predictors of Bisphosphonate-associated Osteonecrosis
of the Jaw (ONJ)
John Markowitz $97,678 1 National Institute of Health Genetic Variants of Human Carboxylesterase 1 Influence the Activation and Antiviral
Activity of Oseltamivir
Charles Peloquin $192,043 1 Jacobus Pharmaceutical A Pharmacokinetic Study of 3,4 DAP in Healthy Volunteers
$7,200 1 Multiple Sponsors Multiple Sponsors
$74,495 3 Rhode Island Hospital Pharmacogenetics and Drug-Drug Interactions During HIV and TB Therapy
$18,117 1 Harvard University Randomized Trial of High-dose Rifampin
$57,475 1 Merck - University of Texas The Effect of Rifapentine on Plasma Concentrations of Raltegravir
$23,525 1 Case Western Reserve University Tuberculosis Research Unit (TBRU)
Karen Sando $40,000 1 Florida Department of Health AHEC Tobacco Training and Cessation Program
Kristen Weitzel $1,000 1 American Pharmacists Association Use of an iPad with Electronic Medical Record Software to Facilitate Patient Care in a
Pharmacist-run Ambulatory Care Clinic
Return to Table of Contents
43
25th
ANNUAL RESEARCH
SHOWCASE AND AWARDS
RECOGNITION DAY
THURSDAY, FEBRUARY 16
th, 2012
UNIVERSITY OF FLORIDA
COLLEGE OF PHARMACY
A SPECIAL THANKS TO THIS YEAR’S SPONSORS
PLATINUM SPONSOR
Drug & Biotechnology Development, LLC
Clearwater, FL
Dr. Robert G. and Maria Bell; Class of 1988
Nanotherapeutics, Inc.
Alachua, FL
Dr. James Talton; Class of 1999
Poster Competition Sponsor
GOLD SPONSORS
DENALI BioTechnologies, LLC
Soldotna, AK
Dr. Maureen McKenzie
Dr. Robert A. and Phyllis Levitt
Gainesville, FL; Class of 1961
Levitt Division, Oral Competition Sponsor
Dr. David W. Newton
Winchester, VA; Class of 1976
Debbie Klapp - Memorial Endowment
SILVER SPONSORS
Dr. Gwen (Victoria) De Leon
Orange Park, FL; Class of 1994
with matching gift from Publix
Dr. Yan Gong
Gainesville, FL; Class of 2004
Dr. Christian Hampp
Baltimore, MD; Class of 2009
Dr. H. Thomas Karnes
Richmond, VA; Class of 1984
Dr. Teresa Kauf
Gainesville, FL; Faculty
SPONSORS Dr. Raymond Jurgens
Madison, WI; Class of 1973
Dr. James Sacco
Madison, WI; Class of 2006
44
SCHEDULE OF EVENTS
8:00am - 9:00am Set-up Poster Presentations (Reception Hall, HPNP Building)
POSTER COMPETITION
9:00am - 11:30am Poster Competition – Students Present for Judging
(Reception Hall, HPNP Building)
ORAL COMPETITION
1:00pm - 1:10pm Introduction – Dr. Teresa Kauf, Associate Professor,
Pharmaceutical Outcomes and Policy (Room G-101, HPNP
Building)
Levitt Division (20 minute presentations)
1:10pm - 1:30pm Steven Bird
1:30pm - 1:50pm Efe Eworuke
Junior Division (15 minute presentations)
1:55pm - 2:10pm Bhargava Kandala
2:10pm - 2:25pm Rana Montaser
2:25pm - 2:40pm Lilibeth Salvador
2:40pm - 2:50pm BREAK
Senior Division (20 minute presentations)
2:55pm - 3:15pm Daniela Conrado
3:15pm - 3:35pm Yue Liu
3:35pm - 3:55pm Rui Wang
4:00pm - 5:15pm Keynote Address Maria Miralles, PhD, Senior Pharmaceutical
Management Advisor, United States Agency International Development
(USAID), “Pharmaceuticals in the Global Health Research Agenda: A
Donor’s Perspective” (Room G-114, HPNP Building)
5:15pm - 7:00pm Awards Reception – Refreshments and Announcement of
Winners (Reception Hall, HPNP Building)
ORAL COMPETITION
LEVITT DIVISION
#1 Presenter: Steven Bird
Department: Pharmaceutical Outcomes and Policy
Research Title: Risk of Venous Thromboembolism with Drospirenone: A Population-
based Comparative-safety Study
#2 Presenter: Efe Eworuke
Department: Pharmaceutical Outcomes and Policy
Research Title: Drug Utilization Patterns for Routine Therapies in Patients with Cystic
Fibrosis
JUNIOR DIVISION
#1 Presenter: Bhargava Kandala
Department: Pharmaceutics
Research Title: Design and Analysis of Pharmacodynamic Crossover Studies
Conducted to Establish Bioequivalence of Inhaled Corticosteroids
#2 Presenter: Rana Montaser
Department: Medicinal Chemistry
Research Title: Drugs from the Sea: Chemical and Biological Characterization of Novel
Fatty Acid Derivatives from the Guamanian Marine Cyanobacteria
Lyngbya spp.
#3 Presenter: Lilibeth Salvador
Department: Medicinal Chemistry
Research Title: Novel Bioactive Natural Products from the Marine Cyanobacterium
Symploca sp. as Leads for Drug Discovery
SENIOR DIVISION
#1 Presenter: Daniela Conrado
Department: Pharmaceutics
Research Title: Pharmacokinetic-Pharmacodynamic Modeling of Armodafinil: Effects
on Electroencephalogram and Neurocognition of Sleep Deprived Adults
#2 Presenter: Yue Liu
Department: Pharmacodynamics
Research Title: Involvement of Mitochondrial Complexes in Divalent Manganese-
stimulated Release of Hydrogen Peroxide in Microglial Cells
#3 Presenter: Rui Wang
Department: Medicinal Chemistry
Research Title: Biological Mode of Action Study of a Small Molecule Inducer of the
Antioxidant Response Element
45
POSTER COMPETITION
# 1 Modulation of Voluntary Alcohol Consumption by 5-HT2A/C Receptor Subtypes: A
Promising Target for Treating Alcoholism
Presenter: Richard Aramini and Sarah Bisceglia (Pharmacodynamics/Professional
Students)
Authors: R Aramini, S Bisceglia, R Tikamdas, P Cogan, K Chen Yin, J Kasper, M
Kim, C Canal, R booth, J Peris
# 2 Retrospective Study of Drotrecogin Alpha (Activated) Use in Burn Patients
Presenter: Kristi Beermann (Shands, University of Florida/Professional Student)
Authors: K Beermann, A LeClaire, N Ladikos, D Mozingo
# 3 A Discriminative Analytical Method for Detection of CES1A1 and CES1A2/CES1A3
Genetic Variants
Presenter: Bryan Brinda (Pharmacotherapy & Translational Research/Professional
Student)
Authors: H Zhu, B Brinda, J Markowitz
# 4 Educational Interventions Targeting Students of Health Care Disciplines to Improve
Cultural Competencies Specific to Caring for People with Disabilities
Presenter: Lori Carter (Pharmaceutical Outcomes & Policy/Professional Student)
Authors: L Carter, D Wilson, WT Smith
# 5 Impact of Computerized Physician Order Entry (CPOE) on the Safety of Patient-
controlled Analgesia
Presenter: Caitlin Dickens (College of Medicine, Department of Anesthesiology/
Professional Student)
Authors: C Dickens, J Waldfogel
# 6 Ototopical Neomycin Exposure in Children with Non-intact Tympanic Membranes
Presenter: Juan Hincapie-Castillo (Pharmaceutical Outcomes & Policy/Professional
Student)
Authors: J Hincapie-Castillo, A Winterstein, P Antonelli, P Kubilis, D Xu
# 7 The Effects of Dietary Polyunsaturated Fatty Acids on Pain Response in Third
Molar Surgery Patients
Presenter: Danielle Honein (Pharmacotherapy & Translational Research/Professional
Student)
Authors: D Honein, B Hastie, M Stavropoulos, M Wallace, R Frye
POSTER COMPETITION (cont.)
# 8 Analysis of the Time-to-Positivity of Blood Cultures at a Tertiary Care Hospital:
Antimicrobial Stewardship Implications
Presenter: Joseph Pardo (Shands, University of Florida/Professional Student)
Authors: J Pardo, K Klinker, S Borgert, G Trikha, R Ramphal
# 9 Drug-associated Health Outcomes of Interest: A Systematic Review of Published
Literature
Presenter: Sarah Valentine (Pharmaceutical Outcomes and Policy/Professional Student)
Authors: S Valentine, A Hartzema
# 10 A Novel 5-HT2C Agonist/5-HT2A Antagonist Attenuates the Increase in Voluntary
Ethanol Consumption Seen After a Period of Alcohol Deprivation in Rats
Presenter: Joshua Winegar (Pharmacodynamics/Professional Student)
Authors: J Winegar, C Doyle, A George, K MacFadyen, J Kasper, M Kim, C Canal, R
Booth, J Peris
# 11 Immunization Error Rate With and Without the Use of a Standardized Order Set in
an Ambulatory Pediatric Clinic Using a Computerized Physician Order Entry
System
Presenter: Carolyn Smith (Pharmacotherapy & Translational Research/Post-doctoral
Fellow)
Authors: C Smith, S Ryan, J Moxley, L Thames, A Schentrup
# 12 Association of FTO with Hydrochlorothiazide-induced Elevation in Uric Acid in
African American Hypertensives in the Pharmacogenomic Evaluation of
Antihypertensive Response (PEAR) Study
Presenter: Alexander Vandell (Pharmacotherapy & Translational Research/Post-
doctoral Fellow)
Authors: A Vandell, C McDonough, T Langaee, B Burkley, Y Gong, S Turner, J
Gums, A Chapman, A Beitelshees, K Bailey, E Boerwinkle, R Cooper-
DeHoff, J Johnson
# 13 Comparison of Suboptimal Treatments Identified from Claims Data Alone with a
Medication Therapy Management Patient Interview
Presenter: Tsu-Hsuan Yang (Pharmaceutical Outcomes and Policy/Post-doctoral
Fellow)
Authors: T-H Yang, D Folmar, S Stevens, R Segal, A Wolf, P Sessions, J Lannigan
46
POSTER COMPETITION (cont.)
# 14 Non-synonymous SNPs in SELE, SELP, and SIGLEC12 Associated with
Cardiovascular (CV) Outcomes in the INternational VErapamil SR-Trandolapril
STudy GENEtic Substudy (INVEST-GENES)
Presenter: Caitrin McDonough (Pharmacotherapy & Translational Research/Post-
doctoral Fellow)
Authors: C McDonough, B Burkley, Y Gong, T Langaee, C Pepine, R Cooper-
DeHoff, J Johnson
# 15 Inhibitory Effect of Six Commonly used Herbal Extracts on CYP2C8 Enzyme
Activity
Presenter: Ahmed Albassam (Pharmacotherapy & Translational Research/Graduate
Student)
Authors: A Albassam, R Frye
# 16 Exploratory Pharmacokinetics-Pharmacodynamics (PK-PD) Target Attainment
Analysis of PA-824
Presenter: Aline Barth (Pharmaceutics/Graduate Student)
Authors: A Barth, R Singh, E Egelund, Z Ahmad, E Nuermberger, C Peloquin, H
Derendorf
# 17 Compound-21, an AT2R Agonist, as a Novel Drug Therapy for Pulmonary
Hypertension
Presenter: Erin Bruce (Pharmacodynamics/Graduate Student)
Authors: E Bruce, V Shenoy, A Rathinasabapathy, U Steckelings, T Unger, M
Raizada, C Sumners, M Katovich
# 18 A Novel Approach of Regenerative Medicine for the Treatment of Alpha 1
Antitrypsin Deficiency
Presenter: Mong-Jen Chen (Pharmaceutics/Graduate Student)
Authors: M-J Chen, Y Lu, T Hamazaki, H-Y Tsai, A Srivastava, V Chiodo, W
Hauswirth, N Terada, S Song
# 19 Cortisol Increases Activated Caspase-3 in Conductive Cells in the Fetal Heart
Presenter: Xiaodi Feng (Pharmacodynamics/Graduate Student)
Authors: X Feng, M Keller-Wood
# 20 Breath Testing to Assess Definitive Adherence to Oral and Vaginal Medications
Presenter: Daniel Gonzalez (Pharmaceutics/Graduate Student)
Authors: D Gonzalez, T Morey, S Wasdo, J Wishin, B Quinn, A van der Straten, M
Booth, H Derendorf, R Melker, D Dennis
POSTER COMPETITION (cont.)
# 21 Synthesis of an Enzyme-cleavable Macromolecular Prodrug of Valproic Acid for
Targeted Drug Delivery
Presenter: AM Hassan (Pharmaceutics/Graduate Student)
Authors: AM Hassan, V Rolle, G Hochhaus
# 22 Exploring the Effects of Ammi visnaga on Kidney Stone Prevention:
Pharmacokinetic Evaluation of Ammi visnaga Extract and Visnagin in Rats
Presenter: Karin Haug (Pharmaceutics/Graduate Student)
Authors: K Haug, B Weber, G Hochhaus, V Butterweck
# 23 Novel 5-HT2C Receptor Agonists Alter Reward Pathway GABA Release in Rats: A
Promising Alcoholism Pharmacotherapy
Presenter: James Kasper (Pharmacodynamics/Graduate Student)
Authors: J Kasper, Z Sun, R Booth, J Peris
# 24 Preclinical Antipsychotic Efficacy of Novel Phenylaminotetralin (PAT) Analogs
Acting at Serotonin 5-HT2 Receptors
Presenter: Krishnakanth Kondabolu (Medicinal Chemistry/Graduate Student)
Authors: K Kondabolu, D Morgan, R Sakhuja, R Booth
# 25 Conjugation Causes Low Bioavailability of Gamma-mangostin in Rats
Presenter: Li Li (Pharmaceutics/Graduate Student)
Authors: L Li, A-R Han, A Kinghorn, R Frye, H Derendorf, V Butterweck
# 26 Population Pharmacokinetic Modeling of Methylprednisolone and Prednisolone
after Multiple Oral Dosing in Health Subjects
Presenter: Li Li (Pharmaceutics/Graduate Student)
Authors: L Li, H Möllmann, J Barth, S Rohatagi, G Hochhaus, H Derendorf
# 27 Psychotropic Polypharmacy in Pediatric Patients with ADHD, 1999-006
Presenter: Xinyue Liu (Pharmaceutical Outcomes and Policy/Graduate Student)
Authors: X Liu, P Kubilis, A Winterstein
# 28 A Novel 5-HT2C agonist/5-HT2A Antagonist Attenuates the Increase in Voluntary
Ethanol Consumption Seen After a Period of Alcohol Deprivation in Rats
Presenter: Kaley MacFadyen (Pharmacodynamics/Graduate Student)
Authors: K MacFadyen, C Doyle, J Winegar, A George, J Kasper, M Kim, C Canal, R
Booth, J Peris
47
POSTER COMPETITION (cont.)
# 29 Polymorphisms in Both CYP3A5 and ABCB1 (MDRI/P-gp) are Risk Factors for
Adverse Events in Jordanian Pediatric Renal Transplant Patients on Tacrolimus
Presenter: Sherwin Sy (Pharmaceutics/Graduate Student)
Authors: S Sy, R Singh, S Shilbayeh, R Zmeili, D Conrado, H Derendorf
# 30 Modulation of Voluntary Alcohol Consumption by 5-HT2A/C Receptor Subtypes: A
Promising Target for Treating Alcoholism
Presenter: Rajiv Tikamdas (Pharmacodynamics/Graduate Student)
Authors: R Tikamdas, R Aramini, S Bisceglia, P Cogan, K Chen, J Kasper, M Kim, C
Canal, R Booth, J Peris
# 31 Pharmacokinetic/Pharmacodynamic Modeling of In Vitro Activity of Vertilmicin, A
Novel Aminoglycoside Against Three Bacterial Strains
Presenter: Luning Zhuang (Pharmaceutics/Graduate Student)
Authors: L Zhuang, S Sy, H Xia, A Barbour, R Singh, C Liu, H Derendorf
JUDGES
POSTER COMPETITION
Abdolreza Davoodi-Semiromi, PhD
Research Assistant Professor
Pharmacotherapy & Translational Research
College of Pharmacy
University of Florida
Eric Krause, PhD
Assistant Professor
Pharmacodynamics
College of Pharmacy
University of Florida
Larry Lesko, PhD
Professor
Center for Pharmacometrics & System
Pharmacology
College of Pharmacy
University of Florida
Michael Philbin, PharmD
Senior Clinical Science Manager
Abbott
Winter Garden, FL
Teresa Roane, PharmD
Clinical Assistant Professor
Pharmacotherapy & Translational Research
MTM Communication and Care Center
College of Pharmacy
University of Florida
Stephan Schmidt, PhD
Assistant Professor
Center for Pharmacometrics & System
Pharmacology
College of Pharmacy
University of Florida
ORAL COMPETITION
Maureen McKenzie, PhD
Chief Executive Officer
DENALI BioTechnologies, Inc.
Soldotna, AK
Maria Miralles, PhD
Senior Pharmaceutical Management Advisor
United States Agency International
Development (USAID)
Washington, DC
Robert Navarro, PhD
Clinical Professor
Pharmaceutical Outcomes and Policy
College of Pharmacy
University of Florida
Larry Lopez, PharmD
Emeritus Professor
Pharmacotherapy & Translational Research
College of Pharmacy
University of Florida
Return to Table of Contents